☰

René S. Kahn, MD, PhD - Publications

Affiliations: 
Psychiatry Rudolf Magnus Institute of Neuroscience 
Website:
https://www.knaw.nl/nl/leden/leden/6810
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

500/500 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Wannan CMJ, Nelson B, Addington J, Allott K, Anticevic A, Arango C, Baker JT, Bearden CE, Billah T, Bouix S, Broome MR, Buccilli K, Cadenhead KS, Calkins ME, Cannon TD, ... ... Kahn RS, et al. Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for Psychosis. Schizophrenia Bulletin. PMID 38451304 DOI: 10.1093/schbul/sbae011  0.43
2023 Ge R, Yu Y, Qi YX, Fan YV, Chen S, Gao C, Haas SS, Modabbernia A, New F, Agartz I, Asherson P, Ayesa-Arriola R, Banaj N, Banaschewski T, Baumeister S, ... ... Kahn RS, et al. Normative Modeling of Brain Morphometry Across the Lifespan Using CentileBrain: Algorithm Benchmarking and Model Optimization. Biorxiv : the Preprint Server For Biology. PMID 38076938 DOI: 10.1101/2023.01.30.523509  0.528
2023 Schijven D, Postema MC, Fukunaga M, Matsumoto J, Miura K, de Zwarte SMC, van Haren NEM, Cahn W, Hulshoff Pol HE, Kahn RS, Ayesa-Arriola R, Ortiz-García de la Foz V, Tordesillas-Gutierrez D, Vázquez-Bourgon J, Crespo-Facorro B, et al. Large-scale analysis of structural brain asymmetries in schizophrenia via the ENIGMA consortium. Proceedings of the National Academy of Sciences of the United States of America. 120: e2213880120. PMID 36976765 DOI: 10.1073/pnas.2213880120  0.312
2023 Haas SS, Ge R, Agartz I, Amminger GP, Andreassen OA, Bachman P, Baeza I, Choi S, Colibazzi T, Cropley VL, de la Fuente-Sandoval C, Ebdrup BH, Fortea A, Fusar-Poli P, Glenthøj BY, ... ... Kahn RS, et al. Normative modeling of brain morphometry in Clinical High-Risk for Psychosis. Biorxiv : the Preprint Server For Biology. PMID 36711551 DOI: 10.1101/2023.01.17.523348  0.552
2022 Demjaha A, Galderisi S, Glenthøj B, Arango C, Mucci A, Lawrence A, O'Daly O, Kempton M, Ciufolini S, Baandrup L, Ebdrup BH, Rodriguez-Jimenez R, Diaz-Marsa M, Díaz-Caneja CM, Winter van Rossum I, ... Kahn R, et al. Negative symptoms in First-Episode Schizophrenia related to morphometric alterations in orbitofrontal and superior temporal cortex: the OPTiMiSE study. Psychological Medicine. 1-9. PMID 35197142 DOI: 10.1017/S0033291722000010  0.32
2021 Vissink CE, Winter-van Rossum I, Cannon TD, Fusar-Poli P, Kahn RS, Bossong MG. Structural Brain Volumes of Individuals at Clinical High Risk for Psychosis: A Meta-analysis. Biological Psychiatry Global Open Science. 2: 147-152. PMID 36325161 DOI: 10.1016/j.bpsgos.2021.09.002  0.39
2021 Lehet M, Tso IF, Park S, Neggers SFW, Thompson IA, Kahn RS, Thakkar KN. Altered Effective Connectivity within an Oculomotor Control Network in Unaffected Relatives of Individuals with Schizophrenia. Brain Sciences. 11. PMID 34573248 DOI: 10.3390/brainsci11091228  0.325
2020 Dazzan P, Lawrence AJ, Reinders AATS, Egerton A, van Haren NEM, Merritt K, Barker GJ, Perez-Iglesias R, Sendt KV, Demjaha A, Nam KW, Sommer IE, Pantelis C, Wolfgang Fleischhacker W, van Rossum IW, ... ... Kahn RS, et al. Symptom Remission and Brain Cortical Networks at First Clinical Presentation of Psychosis: The OPTiMiSE Study. Schizophrenia Bulletin. PMID 33057670 DOI: 10.1093/schbul/sbaa115  0.307
2020 de Zwarte SMC, Brouwer RM, Agartz I, Alda M, Alonso-Lana S, Bearden CE, Bertolino A, Bonvino A, Bramon E, Buimer EEL, Cahn W, Canales-Rodríguez EJ, Cannon DM, Cannon TD, Caseras X, ... ... Kahn RS, et al. Intelligence, educational attainment, and brain structure in those at familial high-risk for schizophrenia or bipolar disorder. Human Brain Mapping. PMID 33027543 DOI: 10.1002/hbm.25206  0.519
2020 Janssen J, Díaz-Caneja CM, Alloza C, Schippers A, de Hoyos L, Santonja J, Gordaliza PM, Buimer EEL, van Haren NEM, Cahn W, Arango C, Kahn RS, Hulshoff Pol HE, Schnack HG. Dissimilarity in Sulcal Width Patterns in the Cortex can be Used to Identify Patients With Schizophrenia With Extreme Deficits in Cognitive Performance. Schizophrenia Bulletin. PMID 32964935 DOI: 10.1093/schbul/sbaa131  0.342
2020 Yao B, Neggers SFW, Kahn RS, Thakkar KN. Altered thalamocortical structural connectivity in persons with schizophrenia and healthy siblings. Neuroimage. Clinical. 28: 102370. PMID 32798913 DOI: 10.1016/j.nicl.2020.102370  0.328
2020 Ormel PR, Böttcher C, Gigase FAJ, Missall RD, van Zuiden W, Fernández Zapata MC, Ilhan D, de Goeij M, Udine E, Sommer IEC, Priller J, Raj T, Kahn RS, Hol EM, de Witte LD. A characterization of the molecular phenotype and inflammatory response of schizophrenia patient-derived microglia-like cells. Brain, Behavior, and Immunity. PMID 32798663 DOI: 10.1016/J.Bbi.2020.08.012  0.406
2020 Correll CU, Newcomer JW, Silverman B, DiPetrillo L, Graham C, Jiang Y, Du Y, Simmons A, Hopkinson C, McDonnell D, Kahn RS. Effects of Olanzapine Combined With Samidorphan on Weight Gain in Schizophrenia: A 24-Week Phase 3 Study. The American Journal of Psychiatry. appiajp202019121279. PMID 32791894 DOI: 10.1176/Appi.Ajp.2020.19121279  0.383
2020 Thygesen JH, Presman A, Harju-Seppänen J, Irizar H, Jones R, Kuchenbaecker K, Lin K, Alizadeh BZ, Austin-Zimmerman I, Bartels-Velthuis A, Bhat A, Bruggeman R, Cahn W, Calafato S, Crespo-Facorro B, ... ... Kahn R, et al. Genetic copy number variants, cognition and psychosis: a meta-analysis and a family study. Molecular Psychiatry. PMID 32719466 DOI: 10.1038/S41380-020-0820-7  0.402
2020 Fountoulakis KN, Moeller HJ, Kasper S, Tamminga C, Yamawaki S, Kahn R, Tandon R, Correll CU, Javed A. The report of the joint WPA/CINP workgroup on the use and usefulness of antipsychotic medication in the treatment of schizophrenia. Cns Spectrums. 1-75. PMID 32594935 DOI: 10.1017/S1092852920001546  0.339
2020 Troudet R, Ali WBH, Bacq-Daian D, Rossum IWV, Boland-Auge A, Battail C, Barau C, Rujescu D, McGuire P, Kahn RS, Deleuze JF, Leboyer M, Jamain S. Gene expression and response prediction to amisulpride in the OPTiMiSE first episode psychoses. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 32450569 DOI: 10.1038/S41386-020-0703-2  0.32
2020 Baandrup L, Allerup P, Nielsen MØ, Bak N, Düring SW, Leucht S, Galderisi S, Mucci A, Bucci P, Arango C, Díaz-Caneja CM, Dazzan P, McGuire P, Demjaha A, Ebdrup BH, ... Kahn RS, et al. Rasch analysis of the PANSS negative subscale and exploration of negative symptom trajectories in first-episode schizophrenia - data from the OPTiMiSE trial. Psychiatry Research. 289: 112970. PMID 32438207 DOI: 10.1016/J.Psychres.2020.112970  0.336
2020 Correll CU, Newcomer JW, Silverman B, DiPetrillo L, Graham C, Jiang Y, Du Y, Simmons A, Hopkinson C, McDonnell D, Kahn R. 100 Olanzapine/Samidorphan for Schizophrenia: Weight Gain and Metabolic Outcomes in Phase 3 ENLIGHTEN-2 and Subsequent Long-Term, Open-Label Safety Study. Cns Spectrums. 25: 265. PMID 32331090 DOI: 10.1017/S1092852920000188  0.309
2020 Boks MP, He Y, Schubart CD, van Gastel W, Elkrief L, Huguet G, van Eijk K, Vinkers CH, Kahn RS, Paus T, Conrod P, Hol EM, de Witte LD. Cannabinoids and psychotic symptoms: A potential role for a genetic variant in the P2X purinoceptor 7 (P2RX7) gene. Brain, Behavior, and Immunity. PMID 32330591 DOI: 10.1016/J.Bbi.2020.04.051  0.304
2020 Bucci P, Mucci A, van Rossum IW, Aiello C, Arango C, Baandrup L, Buchanan RW, Dazzan P, Demjaha A, Díaz-Caneja CM, Giordano GM, Glenthøj BY, Leucht S, McGuire P, Rodriguez-Jimenez R, ... ... Kahn RS, et al. Persistent negative symptoms in recent-onset psychosis: Relationship to treatment response and psychosocial functioning. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 32291210 DOI: 10.1016/J.Euroneuro.2020.03.010  0.349
2020 Kahn RS. On the Origins of Schizophrenia. The American Journal of Psychiatry. 177: 291-297. PMID 32233682 DOI: 10.1176/Appi.Ajp.2020.20020147  0.416
2020 Higgins-Chen AT, Boks MP, Vinkers CH, Kahn RS, Levine ME. Schizophrenia and Epigenetic Aging Biomarkers: Increased Mortality, Reduced Cancer Risk, and Unique Clozapine Effects. Biological Psychiatry. PMID 32199607 DOI: 10.1016/J.Biopsych.2020.01.025  0.318
2020 Grasby KL, Jahanshad N, Painter JN, Colodro-Conde L, Bralten J, Hibar DP, Lind PA, Pizzagalli F, Ching CRK, McMahon MAB, Shatokhina N, Zsembik LCP, Thomopoulos SI, Zhu AH, Strike LT, ... ... Kahn RS, et al. The genetic architecture of the human cerebral cortex. Science (New York, N.Y.). 367. PMID 32193296 DOI: 10.1126/Science.Aay6690  0.541
2020 Chand GB, Dwyer DB, Erus G, Sotiras A, Varol E, Srinivasan D, Doshi J, Pomponio R, Pigoni A, Dazzan P, Kahn RS, Schnack HG, Zanetti MV, Meisenzahl E, Busatto GF, et al. Two distinct neuroanatomical subtypes of schizophrenia revealed using machine learning. Brain : a Journal of Neurology. PMID 32103250 DOI: 10.1093/Brain/Awaa025  0.368
2020 van Haren NEM, Setiaman N, Koevoets MGJC, Baalbergen H, Kahn RS, Hillegers MHJ. Brain structure, IQ, and psychopathology in young offspring of patients with schizophrenia or bipolar disorder. European Psychiatry : the Journal of the Association of European Psychiatrists. 63: e5. PMID 32093799 DOI: 10.1192/J.Eurpsy.2019.19  0.443
2020 Okhuijsen-Pfeifer C, Sterk AY, Horn IM, Terstappen J, Kahn RS, Luykx JJ. Demographic and clinical features as predictors of clozapine response in patients with schizophrenia spectrum disorders: a systematic review and meta-analysis. Neuroscience and Biobehavioral Reviews. PMID 31982601 DOI: 10.1016/J.Neubiorev.2020.01.017  0.384
2020 van Leeuwen JMC, Vinkers CH, Vink M, Kahn RS, Joëls M, Hermans EJ. Disrupted upregulation of salience network connectivity during acute stress in siblings of schizophrenia patients. Psychological Medicine. 1-11. PMID 31941558 DOI: 10.1017/S0033291719004033  0.733
2020 Renkema TC, Haan Ld, Schirmbeck F, Alizadeh BZ, Amelsvoort Tv, Bartels-Velthuis AA, Beveren NJv, Bruggeman R, Cahn W, Delespaul P, Luykx JJ, Myin-Germeys I, Kahn RS, Simons CJP, Os Jv, et al. Childhood trauma and coping in patients with psychotic disorders and obsessive-compulsive symptoms and in un-affected siblings. Child Abuse & Neglect. 99: 104243. PMID 31783309 DOI: 10.1016/J.Chiabu.2019.104243  0.304
2020 Zwarte SMCd, Brouwer RRM, Kahn RS, Turner JA, Erp TGMv, Andreasen OA, Ching CRK, Jahanshad N, Thompson PM, Haren NV, Relatives E. M166. The Effect Of Intelligence And Educational Attainment On The Brain In Those With Familial High Risk For Schizophrenia Or Bipolar Disorder: An Enigma–Relatives Study Schizophrenia Bulletin. 46. DOI: 10.1093/Schbul/Sbaa030.478  0.364
2020 Pina-Camacho L, Diaz-Caneja CM, Fraguas D, Boada L, Parellada M, Winter-van Rossum I, Kahn R, Arango C. T117. PROMINENT AND PERSISTENT AUTISTIC TRAITS ARE ASSOCIATED WITH EARLY NON-REMISSION IN FIRST-EPISODE SCHIZOPHRENIA Schizophrenia Bulletin. 46: S275-S275. DOI: 10.1093/Schbul/Sbaa029.677  0.414
2020 Lyliana N, Winter I, Kahn R, Sommer I. T43. PREDNISOLONE VERSUS PLACEBO AS AUGMENTATION THERAPY IN PSYCHOTIC DISORDERS Schizophrenia Bulletin. 46: S248-S248. DOI: 10.1093/Schbul/Sbaa029.603  0.32
2020 Lehet M, Yao B, Tso IF, Kahn RS, Neggers SF, Thakkar KN. Compromised Neural Circuit Dynamics Underlying Impaired Control of Eye Movements in Schizophrenia Biological Psychiatry. 87: S375-S376. DOI: 10.1016/J.Biopsych.2020.02.961  0.345
2020 Chand G, Wolf DH, Erus G, Srinivasan D, Dwyer DB, Pomponio R, Sotiras A, Varol E, Doshi J, Pigoni A, Dazzan P, Kahn RS, Schnack HG, Zanetti MV, Meisenzahl E, et al. Neuroanatomical Dimensional Phenotypes of Schizophrenia: Expression in Youth With Psychosis-Spectrum Symptoms and Correlation With Cognition Biological Psychiatry. 87: S119. DOI: 10.1016/J.Biopsych.2020.02.324  0.36
2020 van Leeuwen J, Vinkers C, Vink M, Kahn R, Joels M, Hermans E. Neural Temporal Dynamics of Stress in At-Risk Individuals Biological Psychiatry. 87: S89-S90. DOI: 10.1016/J.Biopsych.2020.02.250  0.607
2020 Wolf D, Chand G, Dwyer D, Erus G, Sotiras A, Varol E, Srinivasan D, Doshi J, Pomponio R, Pigoni A, Dazzan P, Kahn RS, Schnack HG, Zanetti MV, Meisenzahl E, et al. Two Neuroanatomical Subtypes of Schizophrenia Defined by Multi-Site Machine Learning Biological Psychiatry. 87: S28-S29. DOI: 10.1016/J.Biopsych.2020.02.097  0.319
2019 Lam M, Chen CY, Li Z, Martin AR, Bryois J, Ma X, Gaspar H, Ikeda M, Benyamin B, Brown BC, Liu R, Zhou W, Guan L, Kamatani Y, Kim SW, ... ... Kahn RS, et al. Comparative genetic architectures of schizophrenia in East Asian and European populations. Nature Genetics. PMID 31740837 DOI: 10.1038/S41588-019-0512-X  0.393
2019 Sneeboer MAM, van der Doef T, Litjens M, Psy NBB, Melief J, Hol EM, Kahn RS, de Witte LD. Microglial activation in schizophrenia: Is translocator 18 kDa protein (TSPO) the right marker? Schizophrenia Research. PMID 31699629 DOI: 10.1016/J.Schres.2019.10.045  0.415
2019 Turk E, van den Heuvel MI, Benders MJ, de Heus R, Franx A, Manning JH, Hect JL, Hernandez-Andrade E, Hassan SS, Romero R, Kahn RS, Thomason ME, van den Heuvel MP. Functional connectome of the fetal brain. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 31685648 DOI: 10.1523/Jneurosci.2891-18.2019  0.302
2019 Sneeboer MAM, van Mierlo HC, Stotijn E, MacIntyre DJ, Smith C, Kahn RS, Hol EM, de Witte LD. Increased number of T-lymphocytes in post-mortem brain tissue of patients with schizophrenia. Schizophrenia Research. PMID 31676171 DOI: 10.1016/J.Schres.2019.10.032  0.394
2019 Satizabal CL, Adams HHH, Hibar DP, White CC, Knol MJ, Stein JL, Scholz M, Sargurupremraj M, Jahanshad N, Roshchupkin GV, Smith AV, Bis JC, Jian X, Luciano M, Hofer E, ... ... Kahn RS, et al. Genetic architecture of subcortical brain structures in 38,851 individuals. Nature Genetics. PMID 31636452 DOI: 10.1038/S41588-019-0511-Y  0.537
2019 Kahn RS. On the Specificity of Continuous Cognitive Decline in Schizophrenia. The American Journal of Psychiatry. 176: 774-776. PMID 31569987 DOI: 10.1176/Appi.Ajp.2019.19080794  0.378
2019 van Leeuwen JMC, Vink M, Joëls M, Kahn RS, Hermans EJ, Vinkers CH. Reward-Related Striatal Responses Following Stress in Healthy Individuals and Patients With Bipolar Disorder. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. PMID 31471186 DOI: 10.1016/J.Bpsc.2019.06.014  0.727
2019 de Zwarte SMC, Brouwer RM, Agartz I, Alda M, Aleman A, Alpert KI, Bearden CE, Bertolino A, Bois C, Bonvino A, Bramon E, Buimer EEL, Cahn W, Cannon DM, Cannon TD, ... ... Kahn RS, et al. The Association Between Familial Risk and Brain Abnormalities Is Disease Specific: An ENIGMA-Relatives Study of Schizophrenia and Bipolar Disorder. Biological Psychiatry. PMID 31443932 DOI: 10.1016/J.Biopsych.2019.03.985  0.595
2019 de Lange SC, Scholtens LH, van den Berg LH, Boks MP, Bozzali M, Cahn W, Dannlowski U, Durston S, Geuze E, van Haren NEM, Hillegers MHJ, Koch K, Jurado MÁ, Mancini M, ... ... Kahn RS, et al. Shared vulnerability for connectome alterations across psychiatric and neurological brain disorders. Nature Human Behaviour. PMID 31384023 DOI: 10.1038/S41562-019-0659-6  0.322
2019 Pandit R, Cianci D, Ter Hark SE, Winter-van Rossum I, Ebdrup BH, Broberg BV, Garcia-Portilla MP, Bobes J, Vinkers CH, Kahn RS, Guloksuz S, Huitema ADR, Luykx JJ. Phenotypic factors associated with amisulpride-induced weight gain in first-episode psychosis patients (from the OPTIMISE cohort). Acta Psychiatrica Scandinavica. PMID 31323113 DOI: 10.1111/Acps.13074  0.312
2019 van den Heuvel MP, Scholtens LH, Kahn RS. Multiscale Neuroscience of Psychiatric Disorders. Biological Psychiatry. PMID 31320130 DOI: 10.1016/J.Biopsych.2019.05.015  0.304
2019 van Mierlo HC, Broen JCA, Kahn RS, de Witte LD. B-cells and schizophrenia: A promising link or a finding lost in translation? Brain, Behavior, and Immunity. PMID 31271869 DOI: 10.1016/J.Bbi.2019.06.043  0.372
2019 Berdenis van Berlekom A, Muflihah CH, Snijders GJLJ, MacGillavry HD, Middeldorp J, Hol EM, Kahn RS, de Witte LD. Synapse Pathology in Schizophrenia: A Meta-analysis of Postsynaptic Elements in Postmortem Brain Studies. Schizophrenia Bulletin. PMID 31192350 DOI: 10.1093/Schbul/Sbz060  0.331
2019 Sneeboer MAM, Snijders GJLJ, Berdowski WM, Fernández-Andreu A, van Mierlo HC, Berdenis van Berlekom A, Litjens M, Kahn RS, Hol EM, de Witte LD. Microglia in post-mortem brain tissue of patients with bipolar disorder are not immune activated. Translational Psychiatry. 9: 153. PMID 31127084 DOI: 10.1038/S41398-019-0490-X  0.303
2019 Stahl EA, Breen G, Forstner AJ, McQuillin A, Ripke S, Trubetskoy V, Mattheisen M, Wang Y, Coleman JRI, Gaspar HA, de Leeuw CA, Steinberg S, Pavlides JMW, Trzaskowski M, Byrne EM, ... ... Kahn RS, et al. Genome-wide association study identifies 30 loci associated with bipolar disorder. Nature Genetics. PMID 31043756 DOI: 10.1038/S41588-019-0397-8  0.31
2019 Bossong MG, van Hell HH, Schubart CD, van Saane W, Iseger TA, Jager G, van Osch MJP, Jansma JM, Kahn RS, Boks MP, Ramsey NF. Acute effects of ∆9-tetrahydrocannabinol (THC) on resting state brain function and their modulation by COMT genotype. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 30975584 DOI: 10.1016/J.Euroneuro.2019.03.010  0.54
2019 Cui LB, Wei Y, Xi YB, Griffa A, De Lange SC, Kahn RS, Yin H, Van den Heuvel MP. Connectome-Based Patterns of First-Episode Medication-Naïve Patients With Schizophrenia. Schizophrenia Bulletin. PMID 30926985 DOI: 10.1093/Schbul/Sbz014  0.453
2019 Chang X, Collin G, Mandl RCW, Cahn W, Kahn RS. Interhemispheric connectivity and hemispheric specialization in schizophrenia patients and their unaffected siblings. Neuroimage. Clinical. 101656. PMID 30660663 DOI: 10.1016/J.Nicl.2019.101656  0.462
2019 Yao B, Neggers SFW, Rolfs M, Rösler L, Thompson IA, Hopman HJ, Ghermezi L, Kahn RS, Thakkar KN. Structural thalamo-frontal hypoconnectivity is related to oculomotor corollary discharge dysfunction in schizophrenia. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 30630882 DOI: 10.1523/Jneurosci.1473-18.2019  0.387
2019 Schirmbeck F, Konijn M, Hoetjes V, Zink M, Haan Ld, Alizadeh BZ, Bartels-Velthuis AA, Bruggeman R, Beveren NJv, Cahn W, Kahn RS, Haren NEv, Haan Ld, Meijer CJ, Simons CJP, et al. Obsessive–compulsive symptoms in psychotic disorders: longitudinal associations of symptom clusters on between- and within-subject levels European Archives of Psychiatry and Clinical Neuroscience. 269: 245-255. PMID 29520640 DOI: 10.1007/S00406-018-0884-4  0.304
2019 Weiser M, Levi L, Leucht S, Rossum IW, Kahn R. 17.1 PREDICTORS OF RELAPSE IN FIRST EPISODE PSYCHOSIS PATIENTS IN REMISSION Schizophrenia Bulletin. 45: S115-S116. DOI: 10.1093/Schbul/Sbz022.065  0.316
2019 Merritt K, Perez-Iglesias R, Sendt K, Goozee R, Jauhar S, Pepper F, Barker GJ, Glenthoj B, Arango C, Lewis S, Kahn R, Stone J, Howes O, Dazzan P, McGuire P, et al. O5.6. REMISSION FROM ANTIPSYCHOTIC TREATMENT IN FIRST EPISODE PSYCHOSIS RELATED TO LONGITUDINAL CHANGES IN BRAIN GLUTAMATE LEVELS Schizophrenia Bulletin. 45: S175-S175. DOI: 10.1093/Schbul/Sbz021.214  0.309
2019 Koevoets M, Prikken M, Hagenaar D, Kahn R, Haren NV. F90. EMOTION PROCESSING AND WHITE MATTER STRUCTURAL CONNECTIVITY IN SCHIZOPHRENIA Schizophrenia Bulletin. 45: S287-S288. DOI: 10.1093/Schbul/Sbz018.502  0.353
2019 Ori A, Loohuis LO, Guintivano J, Clair DS, McQuillin A, Mill J, Sullivan P, Kahn R, Horvath S, Ophoff R. 30 Schizophrenia Is Characterized By Age- And Sex-Specific Effects On Epigenetic Aging European Neuropsychopharmacology. 29. DOI: 10.1016/J.Euroneuro.2019.07.171  0.336
2019 Ori A, Horvath S, Kahn R, Ophoff R. F124EPIGENETIC AGING IN BLOOD IS AFFECTED IN SCHIZOPHRENIA European Neuropsychopharmacology. 29: S1177. DOI: 10.1016/J.Euroneuro.2018.08.204  0.381
2019 Zhang J, Robinson D, Yu J, Gallego J, Fleischhacker WW, Kahn RS, Crespo-Facorro B, Vazquez-Bourgon J, Kane J, Malhotra A, Lencz T. Schizophrenia Polygenic Risk Score Predicts Antipsychotic Treatment Response In Patients With First Episode Psychosis European Neuropsychopharmacology. 29. DOI: 10.1016/J.Euroneuro.2017.08.388  0.376
2019 Chand GB, Dwyer DB, Erus G, Sotiras A, Varol E, Srinivasan D, Gur RC, Gur RE, Dazzan P, Kahn RS, Schnack HG, Zanetti MV, Busatto GF, Facorro BC, Pantelis C, et al. T195. Neuroanatomical Heterogeneity of Schizophrenia Quantified via Semi-Supervised Machine Learning Reveals Two Distinct Subtypes: Results From the PHENOM Consortium Biological Psychiatry. 85: S205-S206. DOI: 10.1016/J.Biopsych.2019.03.518  0.322
2019 Zwarte Sd, Brouwer R, Ching C, Andreassen O, Erp Tv, Turner J, Thompson P, Kahn R, Haren Nv. 21. ENIGMA-Relatives: The Association Between Familial Risk for Schizophrenia or Bipolar Disorder and Brain Abnormalities Biological Psychiatry. 85. DOI: 10.1016/J.Biopsych.2019.03.035  0.396
2018 de Zwarte SMC, Brouwer RM, Tsouli A, Cahn W, Hillegers MHJ, Hulshoff Pol HE, Kahn RS, van Haren NEM. Running in the Family? Structural Brain Abnormalities and IQ in Offspring, Siblings, Parents, and Co-twins of Patients with Schizophrenia. Schizophrenia Bulletin. PMID 30597053 DOI: 10.1093/Schbul/Sby182  0.448
2018 Swets M, van Dijk FA, Schirmbeck F, Peen J, de Haan L, Alizadeh BZ, van Amelsvoort T, Bartels-Velthuis AA, van Beveren NJ, Bruggeman R, Cahn W, Delespaul P, Luykx JJ, Myin-Germeys I, Kahn RS, et al. Patterns of obsessive-compulsive symptoms and social functioning in schizophrenia; a replication study. Psychiatry Research. 271: 421-427. PMID 30537664 DOI: 10.1016/J.Psychres.2018.11.071  0.307
2018 Prikken M, van der Weiden A, Baalbergen H, Hillegers MH, Kahn RS, Aarts H, van Haren NE. Spontaneous low-frequency fluctuations in the neural system for emotional perception in major psychiatric disorders: amplitude similarities and differences across frequency bands Journal of Psychiatry & Neuroscience : Jpn. 44: 1-8. PMID 30525317 DOI: 10.1503/Jpn.180049  0.373
2018 Zhang JP, Robinson D, Yu J, Gallego J, Fleischhacker WW, Kahn RS, Crespo-Facorro B, Vazquez-Bourgon J, Kane JM, Malhotra AK, Lencz T. Schizophrenia Polygenic Risk Score as a Predictor of Antipsychotic Efficacy in First-Episode Psychosis. The American Journal of Psychiatry. appiajp201817121363. PMID 30392411 DOI: 10.1176/Appi.Ajp.2018.17121363  0.412
2018 van Bergen AH, Verkooijen S, Vreeker A, Abramovic L, Hillegers MH, Spijker AT, Hoencamp E, Regeer EJ, Knapen SE, Riemersma-van der Lek RF, Schoevers R, Stevens AW, Schulte PFJ, Vonk R, Hoekstra R, ... ... Kahn RS, et al. The characteristics of psychotic features in bipolar disorder. Psychological Medicine. 1-13. PMID 30303059 DOI: 10.1017/S0033291718002854  0.303
2018 de Nijs J, Schnack HG, Koevoets MGJC, Kubota M, Kahn RS, van Haren NEM, Cahn W. Reward-related brain structures are smaller in patients with schizophrenia and comorbid metabolic syndrome. Acta Psychiatrica Scandinavica. PMID 30264457 DOI: 10.1111/Acps.12955  0.387
2018 van Leeuwen JMC, Vink M, Joëls M, Kahn RS, Hermans EJ, Vinkers CH. Increased responses of the reward circuitry to positive task feedback following acute stress in healthy controls but not in siblings of schizophrenia patients. Neuroimage. PMID 30243958 DOI: 10.1016/J.Neuroimage.2018.09.051  0.656
2018 Boks MP, Houtepen LC, Xu Z, He Y, Ursini G, Maihofer AX, Rajarajan P, Yu Q, Xu H, Wu Y, Wang S, Shi JP, Hulshoff Pol HE, Strengman E, Rutten BPF, ... ... Kahn RS, et al. Genetic vulnerability to DUSP22 promoter hypermethylation is involved in the relation between in utero famine exposure and schizophrenia. Npj Schizophrenia. 4: 16. PMID 30131491 DOI: 10.1038/S41537-018-0058-4  0.358
2018 Kahn RS, Winter van Rossum I, Leucht S, McGuire P, Lewis SW, Leboyer M, Arango C, Dazzan P, Drake R, Heres S, Díaz-Caneja CM, Rujescu D, Weiser M, Galderisi S, Glenthøj B, et al. Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study. The Lancet. Psychiatry. PMID 30115598 DOI: 10.1016/S2215-0366(18)30252-9  0.416
2018 Fiksinski AM, Breetvelt EJ, Lee YJ, Boot E, Butcher N, Palmer L, Chow EWC, Kahn RS, Vorstman JAS, Bassett AS. Neurocognition and adaptive functioning in a genetic high risk model of schizophrenia. Psychological Medicine. 1-8. PMID 30064532 DOI: 10.1017/S0033291718001824  0.381
2018 Kahn RS. On the Continued Benefit of Antipsychotics After the First Episode of Schizophrenia. The American Journal of Psychiatry. 175: 712-713. PMID 30064241 DOI: 10.1176/Appi.Ajp.2018.18060639  0.419
2018 Schür RR, van Leeuwen JMC, Houtepen LC, Joëls M, Kahn RS, Boks MP, Vinkers CH. Glucocorticoid receptor exon 1 methylation and the cortisol stress response in health and disease. Psychoneuroendocrinology. 97: 182-189. PMID 30036796 DOI: 10.1016/J.Psyneuen.2018.07.018  0.57
2018 Oviedo-Salcedo T, de Witte L, Kümpfel T, Kahn RS, Falkai P, Eichhorn P, Luykx J, Hasan A. Absence of cerebrospinal fluid antineuronal antibodies in schizophrenia spectrum disorders - CORRIGENDUM. The British Journal of Psychiatry : the Journal of Mental Science. 1. PMID 29986772 DOI: 10.1192/Bjp.2018.77  0.363
2018 van Erp TGM, Walton E, Hibar DP, Schmaal L, Jiang W, Glahn DC, Pearlson GD, Yao N, Fukunaga M, Hashimoto R, Okada N, Yamamori H, Bustillo JR, Clark VP, Agartz I, ... ... Kahn RS, et al. Cortical Brain Abnormalities in 4474 Individuals With Schizophrenia and 5098 Control Subjects via the Enhancing Neuro Imaging Genetics Through Meta Analysis (ENIGMA) Consortium. Biological Psychiatry. PMID 29960671 DOI: 10.1016/j.biopsych.2018.04.023  0.33
2018 Bilderbeck AC, Penninx BWJH, Arango C, van der Wee N, Kahn R, Winter-van Rossum I, Hayen A, Kas MJ, Post A, Dawson GR. Overview of the clinical implementation of a study exploring social withdrawal in patients with schizophrenia and Alzheimer's disease. Neuroscience and Biobehavioral Reviews. PMID 29940238 DOI: 10.1016/J.Neubiorev.2018.06.019  0.578
2018 Egerton A, Broberg BV, Van Haren N, Merritt K, Barker GJ, Lythgoe DJ, Perez-Iglesias R, Baandrup L, Düring SW, Sendt KV, Stone JM, Rostrup E, Sommer IE, Glenthøj B, Kahn RS, et al. Response to initial antipsychotic treatment in first episode psychosis is related to anterior cingulate glutamate levels: a multicentre H-MRS study (OPTiMiSE). Molecular Psychiatry. PMID 29880882 DOI: 10.1038/S41380-018-0082-9  0.383
2018 de Nijs J, Meijer JH, de Haan L, Meijer CJ, Bruggeman R, van Haren NEM, Kahn RS, Cahn W. Associations between olfactory identification and (social) cognitive functioning: A cross-sectional study in schizophrenia patients and healthy controls. Psychiatry Research. 266: 147-151. PMID 29864614 DOI: 10.1016/J.Psychres.2018.05.009  0.328
2018 Abramovic L, Boks MPM, Vreeker A, Verkooijen S, van Bergen AH, Ophoff RA, Kahn RS, van Haren NEM. White matter disruptions in patients with bipolar disorder. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 29779901 DOI: 10.1016/J.Euroneuro.2018.01.001  0.345
2018 Vorstman JAS, Olde Loohuis LM, Kahn RS, Ophoff RA. Double Hits in Schizophrenia. Human Molecular Genetics. PMID 29767709 DOI: 10.1093/Hmg/Ddy175  0.386
2018 Olde Loohuis LM, Mangul S, Ori APS, Jospin G, Koslicki D, Yang HT, Wu T, Boks MP, Lomen-Hoerth C, Wiedau-Pazos M, Cantor RM, de Vos WM, Kahn RS, Eskin E, Ophoff RA. Transcriptome analysis in whole blood reveals increased microbial diversity in schizophrenia. Translational Psychiatry. 8: 96. PMID 29743478 DOI: 10.1038/S41398-018-0107-9  0.419
2018 van Leeuwen JMC, Vink M, Fernández G, Hermans EJ, Joëls M, Kahn RS, Vinkers CH. At-risk individuals display altered brain activity following stress. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 29483659 DOI: 10.1038/S41386-018-0026-8  0.683
2018 Tomasik J, Smits SL, Leweke FM, Eljasz P, Pas S, Kahn RS, Osterhaus ADME, Bahn S, de Witte LD. Virus discovery analyses on post-mortem brain tissue and cerebrospinal fluid of schizophrenia patients. Schizophrenia Research. PMID 29478863 DOI: 10.1016/J.Schres.2018.02.012  0.385
2018 Linscott RJ, Morton SE, Alizadeh BZ, Bartels-Velthuis AA, Beveren NJV, Bruggeman R, Cahn W, Haan LD, Delespaul P, Meijer CJ, Myin-Germeys I, Kahn RS, Schirmbeck F, Simons CJP, Haren NEV, et al. The Latent Taxonicity of Schizotypy in Biological Siblings of Probands With Schizophrenia. Schizophrenia Bulletin. 44: 922-932. PMID 29036385 DOI: 10.1093/Schbul/Sbx143  0.387
2018 Salcedo TO, Gagsteiger A, de Witte L, Kümpfel T, Kahn R, Falkai P, Eichhorn P, Luykx J, Hasan A. F107. CSF ABNORMALITIES IN SCHIZOPHRENIA AND DEPRESSION: PRELIMINARY RESULTS FROM A LARGE SCALE COHORT Schizophrenia Bulletin. 44: S261-S261. DOI: 10.1093/Schbul/Sby017.638  0.333
2018 van Haren N, Nikita S, Koevoets M, Baalbergen H, Vink M, Mesman E, Kahn R, Hillegers M. F17. DIFFERENCES IN INTRACRANIAL VOLUME, IQ AND PSYCHOPATHOLOGY IN YOUNG OFFSPRING OF PATIENTS AFFECTED WITH SCHIZOPHRENIA OR BIPOLAR DISORDER Schizophrenia Bulletin. 44: S225-S225. DOI: 10.1093/Schbul/Sby017.548  0.693
2018 Boks M, Houtepen L, Xu Z, He Y, Ursini G, Maihofer A, Rajarajan P, Hulshoff Pol H, Rutten B, Jaffe AE, Kleinmann JE, Baker D, Hol E, Akbarian S, Nievergelt C, ... ... Kahn R, et al. O4.1. GENETIC VULNERABILITY TO DUSP22 PROMOTOR HYPERMETHYLATION IS INVOLVED IN THE RELATION BETWEEN IN UTERO FAMINE EXPOSURE AND SCHIZOPHRENIA Schizophrenia Bulletin. 44: S82-S82. DOI: 10.1093/Schbul/Sby015.207  0.372
2018 Van Haren N, Prikken M, van der Weiden A, Baalbergen H, Hillegers M, Aarts H, Kahn R. O2.5. MULTISENSORY INTEGRATION UNDERLYING BODY OWNERSHIP IN SCHIZOPHRENIA AND INDIVIDUALS AT FAMILIAL RISK TO DEVELOP PSYCHOSIS: A STUDY USING THE RUBBER HAND ILLUSION PARADIGM Schizophrenia Bulletin. 44: S77-S77. DOI: 10.1093/Schbul/Sby015.195  0.409
2018 Dazzan P, Reinders AS, Shatzi V, Carletti F, Arango C, Fleischhacker W, Galderisi S, Mucci A, Glenthoj B, Egerton A, Barker G, Leucht S, Meyer-Lindenberg A, Kahn RS, Rujescu D, et al. 31.3 CLINICAL UTILITY OF MRI SCANNING IN FIRST EPISODE PSYCHOSIS Schizophrenia Bulletin. 44: S50-S51. DOI: 10.1093/Schbul/Sby014.129  0.348
2018 Kahn R. 31.1 Optimising The Treatment And Management Of First-Episode Schizophrenia: The Optimise Clinical Trial Schizophrenia Bulletin. 44. DOI: 10.1093/Schbul/Sby014.127  0.337
2018 Schnack H, Binnewies J, Setiaman N, Berdowski W, van Haren N, Kahn R, Hillegers M. F172. INDIVIDUAL PREDICTION OF RISK IN ADOLESCENT OFFSPRING OF PARENTS WITH SCHIZOPHRENIA OR BIPOLAR DISORDER: A MACHINE LEARNING NEUROIMAGING STUDY WITH A CROSS-STAGE VALIDATION Schizophrenia Bulletin. 44: S287-S288. DOI: 10.1016/J.Jaac.2018.07.767  0.327
2018 van Leeuwen J, Vink M, Fernández G, Hermans E, Joëls M, Kahn R, Vinkers C. F228. Functional Activation Abnormalities Following Stress in At-Risk Individuals Biological Psychiatry. 83: S327. DOI: 10.1016/J.Biopsych.2018.02.842  0.617
2018 de Zwarte S, Brouwer R, Tsouli A, Cahn W, Hillegers M, Pol HH, Kahn R, van Haren N. F221. Brain Abnormalities and Cognitive Deficits in First-Degree Relatives of Patients With Schizophrenia Biological Psychiatry. 83: S325. DOI: 10.1016/J.Biopsych.2018.02.835  0.392
2018 Fiksinski A, Breetvelt E, Vorstman J, Lee E, Boot E, Butcher N, Palmer L, Chow E, Kahn R, Bassett A. F207. Neurocognition and Adaptive Functioning in the 22q11.2 Deletion Syndrome Model of Schizophrenia Biological Psychiatry. 83: S319. DOI: 10.1016/J.Biopsych.2018.02.821  0.341
2018 Föcking M, Pollak T, Dicker P, Cagney G, Winter I, Kahn R, McGuire P, Cotter D. O1.7. PROTEOMIC ANALYSIS OF BLOOD BASED SAMPLES FROM THE OPTiMiSE (OPTIMIZATION OF TREATMENT AND MANAGEMENT OF SCHIZOPHRENIA IN EUROPE) STUDY POINT TOWARDS COMPLEMENT PATHWAY PROTEIN CHANGES Schizophrenia Bulletin. 44: S74-S75. DOI: 10.1016/J.Biopsych.2018.02.775  0.313
2018 Breetvelt E, Smit K, Loohuis LO, Ophoff R, Kahn R, Vorstman J. T225. Burden of Rare Coding Variants in the 22q11.2 Deletion Syndrome Region is Associated With Educational Attainment and Schizophrenia Risk Biological Psychiatry. 83. DOI: 10.1016/J.Biopsych.2018.02.562  0.31
2017 Nuninga JO, Bohlken MM, Koops S, Fiksinski AM, Mandl RCW, Breetvelt EJ, Duijff SN, Kahn RS, Sommer IEC, Vorstman JAS. White matter abnormalities in 22q11.2 deletion syndrome patients showing cognitive decline. Psychological Medicine. 1-9. PMID 29143717 DOI: 10.1017/S0033291717003142  0.374
2017 Blakey R, Ranlund S, Zartaloudi E, Cahn W, Calafato S, Colizzi M, Crespo-Facorro B, Daniel C, Díez-Revuelta Á, Di Forti M, Iyegbe C, Jablensky A, Jones R, Hall MH, ... Kahn R, et al. Associations between psychosis endophenotypes across brain functional, structural, and cognitive domains. Psychological Medicine. 1-20. PMID 29094675 DOI: 10.1017/S0033291717002860  0.312
2017 Kahn RS. Why the concept of schizophrenia is still alive and kicking. Psychological Medicine. 1-2. PMID 29072152 DOI: 10.1017/S0033291717002069  0.395
2017 Kelly S, Jahanshad N, Zalesky A, Kochunov P, Agartz I, Alloza C, Andreassen OA, Arango C, Banaj N, Bouix S, Bousman CA, Brouwer RM, Bruggemann J, Bustillo J, Cahn W, ... ... Kahn RS, et al. Widespread white matter microstructural differences in schizophrenia across 4322 individuals: results from the ENIGMA Schizophrenia DTI Working Group. Molecular Psychiatry. PMID 29038599 DOI: 10.1038/Mp.2017.170  0.437
2017 Blokland GAM, Del Re EC, Mesholam-Gately RI, Jovicich J, Trampush JW, Keshavan MS, DeLisi LE, Walters JTR, Turner JA, Malhotra AK, Lencz T, Shenton ME, Voineskos AN, Rujescu D, Giegling I, ... Kahn RS, et al. The Genetics of Endophenotypes of Neurofunction to Understand Schizophrenia (GENUS) consortium: A collaborative cognitive and neuroimaging genetics project. Schizophrenia Research. PMID 28982554 DOI: 10.1016/J.Schres.2017.09.024  0.407
2017 Marsman A, Mandl RCW, Klomp DWJ, Cahn W, Kahn RS, Luijten PR, Hulshoff Pol HE. Intelligence and Brain Efficiency: Investigating the Association between Working Memory Performance, Glutamate, and GABA. Frontiers in Psychiatry. 8: 154. PMID 28966597 DOI: 10.3389/Fpsyt.2017.00154  0.301
2017 van Mierlo HC, Wichers CGK, He Y, Sneeboer MAM, Radstake TRDJ, Kahn RS, Broen JCA, de Witte LD. Telomere quantification in frontal and temporal brain tissue of patients with schizophrenia. Journal of Psychiatric Research. 95: 231-234. PMID 28910708 DOI: 10.1016/J.Jpsychires.2017.09.006  0.431
2017 Collin G, Scholtens LH, Kahn RS, Hillegers MHJ, van den Heuvel MP. Affected Anatomical Rich Club and Structural-Functional Coupling in Young Offspring of Schizophrenia and Bipolar Disorder Patients. Biological Psychiatry. PMID 28734460 DOI: 10.1016/J.Biopsych.2017.06.013  0.41
2017 Vreeker A, Abramovic L, Boks MPM, Verkooijen S, van Bergen AH, Ophoff RA, Kahn RS, van Haren NEM. The relationship between brain volumes and intelligence in bipolar disorder. Journal of Affective Disorders. 223: 59-64. PMID 28728036 DOI: 10.1016/J.Jad.2017.07.009  0.355
2017 Witt SH, Streit F, Jungkunz M, Frank J, Awasthi S, Reinbold CS, Treutlein J, Degenhardt F, Forstner AJ, Heilmann-Heimbach S, Dietl L, Schwarze CE, Schendel D, Strohmaier J, Abdellaoui A, ... ... Kahn RS, et al. Genome-wide association study of borderline personality disorder reveals genetic overlap with bipolar disorder, major depression and schizophrenia. Translational Psychiatry. 7: e1155. PMID 28632202 DOI: 10.1038/Tp.2017.115  0.336
2017 Wei Y, Collin G, Mandl RCW, Cahn W, Keunen K, Schmidt R, Kahn RS, van den Heuvel MP. Cortical magnetization transfer abnormalities and connectome dysconnectivity in schizophrenia. Schizophrenia Research. PMID 28601503 DOI: 10.1016/J.Schres.2017.05.029  0.437
2017 Brouwer RM, Panizzon MS, Glahn DC, Hibar DP, Hua X, Jahanshad N, Abramovic L, de Zubicaray GI, Franz CE, Hansell NK, Hickie IB, Koenis MMG, Martin NG, Mather KA, McMahon KL, ... ... Kahn RS, et al. Genetic influences on individual differences in longitudinal changes in global and subcortical brain volumes: Results of the ENIGMA plasticity working group. Human Brain Mapping. PMID 28580697 DOI: 10.1002/Hbm.23672  0.316
2017 Walton E, Hibar DP, van Erp TGM, Potkin SG, Roiz-Santiañez R, Crespo-Facorro B, Suarez-Pinilla P, van Haren NEM, de Zwarte SMC, Kahn RS, Cahn W, Doan NT, Jørgensen KN, Gurholt TP, Agartz I, et al. Prefrontal cortical thinning links to negative symptoms in schizophrenia via the ENIGMA consortium. Psychological Medicine. 1-13. PMID 28545597 DOI: 10.1017/S0033291717001283  0.418
2017 Hibar DP, Westlye LT, Doan NT, Jahanshad N, Cheung JW, Ching CRK, Versace A, Bilderbeck AC, Uhlmann A, Mwangi B, Krämer B, Overs B, Hartberg CB, Abé C, Dima D, ... ... Kahn RS, et al. Cortical abnormalities in bipolar disorder: an MRI analysis of 6503 individuals from the ENIGMA Bipolar Disorder Working Group. Molecular Psychiatry. PMID 28461699 DOI: 10.1038/Mp.2017.73  0.371
2017 de With SAJ, Pulit SL, Staal WG, Kahn RS, Ophoff RA. More than 25 years of genetic studies of clozapine-induced agranulocytosis. The Pharmacogenomics Journal. PMID 28418011 DOI: 10.1038/Tpj.2017.6  0.634
2017 Walton E, Hibar DP, van Erp TG, Potkin SG, Roiz-Santiañez R, Crespo-Facorro B, Suarez-Pinilla P, Van Haren NE, de Zwarte SM, Kahn RS, Cahn W, Doan NT, Jørgensen KN, Gurholt TP, Agartz I, et al. Positive symptoms associate with cortical thinning in the superior temporal gyrus via the ENIGMA Schizophrenia consortium. Acta Psychiatrica Scandinavica. PMID 28369804 DOI: 10.1111/Acps.12718  0.383
2017 van Kesteren CF, Gremmels H, de Witte LD, Hol EM, Van Gool AR, Falkai PG, Kahn RS, Sommer IE. Immune involvement in the pathogenesis of schizophrenia: a meta-analysis on postmortem brain studies. Translational Psychiatry. 7: e1075. PMID 28350400 DOI: 10.1038/Tp.2017.4  0.44
2017 Keefe RS, Kahn RS. Cognitive Decline and Disrupted Cognitive Trajectory in Schizophrenia. Jama Psychiatry. PMID 28329400 DOI: 10.1001/Jamapsychiatry.2017.0312  0.326
2017 McLaughlin RL, Schijven D, van Rheenen W, van Eijk KR, O'Brien M, Kahn RS, Ophoff RA, Goris A, Bradley DG, Al-Chalabi A, van den Berg LH, Luykx JJ, Hardiman O, Veldink JH, et al. Genetic correlation between amyotrophic lateral sclerosis and schizophrenia. Nature Communications. 8: 14774. PMID 28322246 DOI: 10.1038/Ncomms14774  0.404
2017 Chang X, Collin G, Xi Y, Cui L, Scholtens LH, Sommer IE, Wang H, Yin H, Kahn RS, van den Heuvel MP. Resting-state functional connectivity in medication-naïve schizophrenia patients with and without auditory verbal hallucinations: A preliminary report. Schizophrenia Research. PMID 28130005 DOI: 10.1016/J.Schres.2017.01.024  0.432
2017 Fiksinski AM, Breetvelt EJ, Duijff SN, Bassett AS, Kahn RS, Vorstman JA. Autism Spectrum and psychosis risk in the 22q11.2 deletion syndrome. Findings from a prospective longitudinal study. Schizophrenia Research. PMID 28119035 DOI: 10.1016/J.Schres.2017.01.032  0.352
2017 Hibar DP, Adams HH, Jahanshad N, Chauhan G, Stein JL, Hofer E, Renteria ME, Bis JC, Arias-Vasquez A, Ikram MK, Desrivières S, Vernooij MW, Abramovic L, Alhusaini S, Amin N, ... ... Kahn RS, et al. Novel genetic loci associated with hippocampal volume. Nature Communications. 8: 13624. PMID 28098162 DOI: 10.1038/Ncomms13624  0.752
2017 Egerton A, Merritt K, McQueen G, Howes O, Demjaha A, Brugger S, Barker G, Stone J, Dazzan P, Broberg B, van Haren N, Glenthoj B, Kahn R, McGuire P. SA83. Brain Glutamate Levels and Antipsychotic Response in Schizophrenia Schizophrenia Bulletin. 43: S142-S143. DOI: 10.1093/Schbul/Sbx023.081  0.412
2017 Collin G, Hillegers M, Scholtens L, Kahn R, van den Heuvel M. 166. Affected Anatomical Rich Club Core and Structural–Functional Integration in Young Offspring of Schizophrenia and Bipolar Disorder Patients Schizophrenia Bulletin. 43: S84-S84. DOI: 10.1093/Schbul/Sbx021.224  0.413
2017 Van Leeuwen J, Vink M, Fernández G, Hermans E, Joëls M, Kahn R, Vinkers C. The dynamic brain response to stress is impaired in siblings of schizophrenia patients European Neuropsychopharmacology. 27: S548. DOI: 10.1016/S0924-977X(17)31047-7  0.7
2017 Van Leeuwen J, Vink M, Joëls M, Kahn R, Vinkers C. Psychosocial stress and emotion processing in siblings of schizophrenia patients European Neuropsychopharmacology. 27: S76. DOI: 10.1016/S0924-977X(16)31211-1  0.679
2017 Lencz T, Zhang J, Kahn RS, Ophoff R, Wolfgang Fleischhacker W, Emsley R, Robinson D, Correll C, Malhotra A. Pharmacogenetics of Antipsychotic-Induced Weight Gain in Multiple Medication-Naive Cohorts European Neuropsychopharmacology. 27: S499. DOI: 10.1016/J.Euroneuro.2016.09.599  0.306
2017 Zwarte Sd, Brouwer R, Hillegers M, Cahn W, Pol HH, Kahn R, Alpert K, Wang L, Bramon E, Kane F, Murray R, Hajek T, Alda M, Roberts G, Mitchell P, et al. 278. ENIGMA-Relatives – Brain Volumes in First-Degree Relatives of Schizophrenia and Bipolar Patients Biological Psychiatry. 81. DOI: 10.1016/J.Biopsych.2017.02.292  0.43
2016 Prikken M, van der Weiden A, Renes RA, Koevoets MG, Heering HD, Kahn RS, Aarts H, van Haren NE. Abnormal agency experiences in schizophrenia patients: Examining the role of psychotic symptoms and familial risk. Psychiatry Research. 250: 270-276. PMID 28189096 DOI: 10.1016/J.Psychres.2016.10.077  0.385
2016 Zorn JV, Schür RR, Boks MP, Kahn RS, Joëls M, Vinkers CH. Cortisol stress reactivity across psychiatric disorders: A systematic review and meta-analysis. Psychoneuroendocrinology. 77: 25-36. PMID 28012291 DOI: 10.1016/J.Psyneuen.2016.11.036  0.58
2016 Tempelaar WM, Termorshuizen F, MacCabe JH, Boks MP, Kahn RS. Educational achievement in psychiatric patients and their siblings: a register-based study in 30 000 individuals in The Netherlands. Psychological Medicine. 1-9. PMID 27873559 DOI: 10.1017/S0033291716002877  0.338
2016 de Leeuw AS, van Megen HJ, Kahn RS, Westenberg HG. d-cycloserine addition to exposure sessions in the treatment of patients with obsessive-compulsive disorder. European Psychiatry : the Journal of the Association of European Psychiatrists. 40: 38-44. PMID 27837671 DOI: 10.1016/J.Eurpsy.2016.06.011  0.546
2016 Romme IA, de Reus MA, Ophoff RA, Kahn RS, van den Heuvel MP. Connectome Disconnectivity and Cortical Gene Expression in Patients With Schizophrenia. Biological Psychiatry. PMID 27720199 DOI: 10.1016/J.Biopsych.2016.07.012  0.429
2016 Adams HH, Hibar DP, Chouraki V, Stein JL, Nyquist PA, Rentería ME, Trompet S, Arias-Vasquez A, Seshadri S, Desrivières S, Beecham AH, Jahanshad N, Wittfeld K, Van der Lee SJ, Abramovic L, ... ... Kahn RS, et al. Novel genetic loci underlying human intracranial volume identified through genome-wide association. Nature Neuroscience. PMID 27694991 DOI: 10.1038/Nn.4398  0.732
2016 de Wit S, Wierenga LM, Oranje B, Ziermans TB, Schothorst PF, van Engeland H, Kahn RS, Durston S. Brain development in adolescents at ultra-high risk for psychosis: Longitudinal changes related to resilience. Neuroimage. Clinical. 12: 542-549. PMID 27672558 DOI: 10.1016/J.Nicl.2016.08.013  0.315
2016 Abramovic L, Boks MP, Vreeker A, Bouter DC, Kruiper C, Verkooijen S, van Bergen AH, Ophoff RA, Kahn RS, van Haren NE. The association of antipsychotic medication and lithium with brain measures in patients with bipolar disorder. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 27665062 DOI: 10.1016/J.Euroneuro.2016.09.371  0.382
2016 van der Doef TF, de Witte LD, Sutterland AL, Jobse E, Yaqub M, Boellaard R, de Haan L, Eriksson J, Lammertsma AA, Kahn RS, van Berckel BN. In vivo (R)-[(11)C]PK11195 PET imaging of 18kDa translocator protein in recent onset psychosis. Npj Schizophrenia. 2: 16031. PMID 27602389 DOI: 10.1038/Npjschz.2016.31  0.371
2016 Schür RR, Boks MP, Geuze E, Prinsen HC, Verhoeven-Duif NM, Joëls M, Kahn RS, Vermetten E, Vinkers CH. Development of psychopathology in deployed armed forces in relation to plasma GABA levels. Psychoneuroendocrinology. 73: 263-270. PMID 27566489 DOI: 10.1016/J.Psyneuen.2016.08.014  0.546
2016 Collin G, Kahn RS. Schizophrenia in the Era of Brain Complexity. The Journal of Nervous and Mental Disease. 204: 561-3. PMID 27479610 DOI: 10.1097/Nmd.0000000000000545  0.413
2016 de Leeuw M, Bohlken MM, Mandl RC, Hillegers MH, Kahn RS, Vink M. Changes in White Matter Organization in Adolescent Offspring of Schizophrenia Patients. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 27440007 DOI: 10.1038/Npp.2016.130  0.711
2016 Schnack H, Haren Nv, Hillegers M, Kahn R. Individual prediction of risk in adolescent offspring of parents with bipolar disorder and schizophrenia using machine learning in MRI brain scans Bipolar Disorders. 18: 64-64. PMID 27373790 DOI: 10.1111/Bdi.12406  0.323
2016 Thakkar KN, Rösler L, Wijnen JP, Boer VO, Klomp DW, Cahn W, Kahn RS, Neggers SF. 7T Proton Magnetic Resonance Spectroscopy of Gamma-Aminobutyric Acid, Glutamate, and Glutamine Reveals Altered Concentrations in Patients With Schizophrenia and Healthy Siblings. Biological Psychiatry. PMID 27316853 DOI: 10.1016/J.Biopsych.2016.04.007  0.367
2016 Buoli M, Kahn RS, Serati M, Altamura AC, Cahn W. Haloperidol versus second-generation antipsychotics in the long-term treatment of schizophrenia. Human Psychopharmacology. PMID 27297936 DOI: 10.1002/Hup.2542  0.401
2016 Bootsman F, Brouwer RM, Schnack HG, Kemner SM, Hillegers MH, Sarkisyan G, van der Schot AC, Vonk R, Hulshoff Pol HE, Nolen WA, Kahn RS, van Haren NE. A study of genetic and environmental contributions to structural brain changes over time in twins concordant and discordant for bipolar disorder. Journal of Psychiatric Research. 79: 116-124. PMID 27218817 DOI: 10.1016/J.Jpsychires.2016.04.011  0.364
2016 Zhang JP, Lencz T, Zhang RX, Nitta M, Maayan L, John M, Robinson DG, Fleischhacker WW, Kahn RS, Ophoff RA, Kane JM, Malhotra AK, Correll CU. Pharmacogenetic Associations of Antipsychotic Drug-Related Weight Gain: A Systematic Review and Meta-analysis. Schizophrenia Bulletin. PMID 27217270 DOI: 10.1093/Schbul/Sbw058  0.302
2016 Janssens M, Boyette LL, Heering HD, Bartels-Velthuis AA, Lataster T, Kahn RS, Haan Ld, Os Jv, Wiersma D, Bruggeman R, Cahn W, Meijer C, Myin-Germeys I. Developmental course of subclinical positive and negative psychotic symptoms and their associations with genetic risk status and impairment Schizophrenia Research. 174: 177-182. PMID 27157801 DOI: 10.1016/J.Schres.2016.03.028  0.303
2016 Schür RR, Draisma LW, Wijnen JP, Boks MP, Koevoets MG, Joëls M, Klomp DW, Kahn RS, Vinkers CH. Brain GABA levels across psychiatric disorders: A systematic literature review and meta-analysis of (1) H-MRS studies. Human Brain Mapping. PMID 27145016 DOI: 10.1002/Hbm.23244  0.61
2016 van Haren NE, Kahn RS. Progressive brain tissue loss in schizophrenia. Schizophrenia Research. PMID 27094719 DOI: 10.1016/J.Schres.2016.03.023  0.398
2016 Thakkar KN, van den Heiligenberg FM, Kahn RS, Neggers SF. Speed of saccade execution and inhibition associated with fractional anisotropy in distinct fronto-frontal and fronto-striatal white matter pathways. Human Brain Mapping. PMID 27091670 DOI: 10.1002/Hbm.23209  0.351
2016 Schnack HG, Kahn RS. Detecting Neuroimaging Biomarkers for Psychiatric Disorders: Sample Size Matters. Frontiers in Psychiatry. 7: 50. PMID 27064972 DOI: 10.3389/Fpsyt.2016.00050  0.338
2016 Bohlken MM, Brouwer RM, Mandl RC, Kahn RS, Hulshoff Pol HE. Genetic Variation in Schizophrenia Liability is Shared With Intellectual Ability and Brain Structure. Schizophrenia Bulletin. PMID 27056715 DOI: 10.1093/Schbul/Sbw034  0.405
2016 Gifford G, Crossley N, Fusar-Poli P, Schnack HG, Kahn RS, Koutsouleris N, Cannon TD, McGuire P. Using neuroimaging to help predict the onset of psychosis. Neuroimage. PMID 27039698 DOI: 10.1016/J.Neuroimage.2016.03.075  0.466
2016 Houtepen LC, Vinkers CH, Carrillo-Roa T, Hiemstra M, van Lier PA, Meeus W, Branje S, Heim CM, Nemeroff CB, Mill J, Schalkwyk LC, Creyghton MP, Kahn RS, Joëls M, Binder EB, et al. Genome-wide DNA methylation levels and altered cortisol stress reactivity following childhood trauma in humans. Nature Communications. 7: 10967. PMID 26997371 DOI: 10.1038/Ncomms10967  0.55
2016 Millan MJ, Andrieux A, Bartzokis G, Cadenhead K, Dazzan P, Fusar-Poli P, Gallinat J, Giedd J, Grayson DR, Heinrichs M, Kahn R, Krebs MO, Leboyer M, Lewis D, Marin O, et al. Altering the course of schizophrenia: progress and perspectives. Nature Reviews. Drug Discovery. PMID 26939910 DOI: 10.1038/Nrd.2016.28  0.43
2016 Landolt K, Rössler W, Ajdacic-Gross V, Derks EM, Libiger J, Kahn RS, Fleischhacker WW. Predictors of discontinuation of antipsychotic medication and subsequent outcomes in the European First Episode Schizophrenia Trial (EUFEST). Schizophrenia Research. PMID 26922655 DOI: 10.1016/J.Schres.2016.01.046  0.349
2016 Schnack HG, van Haren NE, Nieuwenhuis M, Hulshoff Pol HE, Cahn W, Kahn RS. Accelerated Brain Aging in Schizophrenia: A Longitudinal Pattern Recognition Study. The American Journal of Psychiatry. appiajp201515070922. PMID 26917166 DOI: 10.1176/Appi.Ajp.2015.15070922  0.396
2016 Kleerekooper I, van Rooij SJ, van den Wildenberg WP, de Leeuw M, Kahn RS, Vink M. The effect of aging on fronto-striatal reactive and proactive inhibitory control. Neuroimage. PMID 26899783 DOI: 10.1016/J.Neuroimage.2016.02.031  0.64
2016 Hibar DP, Westlye LT, van Erp TG, Rasmussen J, Leonardo CD, Faskowitz J, Haukvik UK, Hartberg CB, Doan NT, Agartz I, Dale AM, Gruber O, Krämer B, Trost S, Liberg B, ... ... Kahn RS, et al. Subcortical volumetric abnormalities in bipolar disorder. Molecular Psychiatry. PMID 26857596 DOI: 10.1038/Mp.2015.227  0.363
2016 Medema S, Mocking RJ, Koeter MW, Vaz FM, Meijer C, de Haan L, van Beveren NJ, Kahn R, de Haan L, van Os J, Wiersma D, Bruggeman R, Cahn W, Meijer C, et al. Levels of Red Blood Cell Fatty Acids in Patients With Psychosis, Their Unaffected Siblings, and Healthy Controls. Schizophrenia Bulletin. 42: 358-68. PMID 26385764 DOI: 10.1093/Schbul/Sbv133  0.346
2016 Collin G, Hilligers MHJ, Scholtens LH, Kahn RS, Heuvel MPVd. Rich club organization of the connectome in children at familial high risk for schizophrenia and bipolar disorder European Neuropsychopharmacology. 26. DOI: 10.1016/S0924-977X(16)31552-8  0.343
2016 Boks MP, Houtepen LC, He Y, Mierlo Hv, Kahn RS, Witte LDd, Vinkers CH. Association of DNA methylation marks in the stress response regulating gene KITLG to schizophrenia and bipolar disorder Psychoneuroendocrinology. 71: 37-37. DOI: 10.1016/J.Psyneuen.2016.07.099  0.352
2015 de Leeuw M, Bohlken MM, Mandl RC, Kahn RS, Vink M. Reduced fronto-striatal white matter integrity in schizophrenia patients and unaffected siblings: a DTI study. Npj Schizophrenia. 1: 15001. PMID 27336028 DOI: 10.1038/npjschz.2015.1  0.69
2015 Kahn RS, Sommer IE, Murray RM, Meyer-Lindenberg A, Weinberger DR, Cannon TD, O'Donovan M, Correll CU, Kane JM, van Os J, Insel TR. Schizophrenia. Nature Reviews. Disease Primers. 1: 15067. PMID 27189524 DOI: 10.1038/nrdp.2015.67  0.522
2015 Renes RA, Vink M, van der Weiden A, Prikken M, Koevoets MG, Kahn RS, Aarts H, van Haren NE. Impaired frontal processing during agency inferences in schizophrenia. Psychiatry Research. PMID 26776080 DOI: 10.1016/J.Pscychresns.2015.12.006  0.712
2015 Maat A, van Haren NE, Bartholomeusz CF, Kahn RS, Cahn W. Emotion recognition and theory of mind are related to gray matter volume of the prefrontal cortex in schizophrenia. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 26711688 DOI: 10.1016/J.Euroneuro.2015.12.013  0.447
2015 Volavka J, Van Dorn RA, Citrome L, Kahn RS, Fleischhacker WW, Czobor P. Hostility in schizophrenia: An integrated analysis of the combined Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and the European First Episode Schizophrenia Trial (EUFEST) studies. European Psychiatry : the Journal of the Association of European Psychiatrists. 31: 13-19. PMID 26657597 DOI: 10.1016/J.Eurpsy.2015.10.003  0.396
2015 van den Heuvel MP, Scholtens LH, de Reus MA, Kahn RS. Associated Microscale Spine Density and Macroscale Connectivity Disruptions in Schizophrenia. Biological Psychiatry. PMID 26632269 DOI: 10.1016/J.Biopsych.2015.10.005  0.437
2015 Vink M, de Leeuw M, Pouwels R, van den Munkhof HE, Kahn RS, Hillegers M. Diminishing striatal activation across adolescent development during reward anticipation in offspring of schizophrenia patients. Schizophrenia Research. PMID 26631365 DOI: 10.1016/J.Schres.2015.11.018  0.71
2015 Bohlken MM, Brouwer RM, Mandl RC, Van den Heuvel MP, Hedman AM, De Hert M, Cahn W, Kahn RS, Hulshoff Pol HE. Structural Brain Connectivity as a Genetic Marker for Schizophrenia. Jama Psychiatry. 1-9. PMID 26606729 DOI: 10.1001/Jamapsychiatry.2015.1925  0.408
2015 Vink M, de Leeuw M, Luykx JJ, van Eijk KR, van den Munkhof HE, van Buuren M, Kahn RS. DRD2 Schizophrenia-Risk Allele Is Associated With Impaired Striatal Functioning in Unaffected Siblings of Schizophrenia Patients. Schizophrenia Bulletin. PMID 26598739 DOI: 10.1093/Schbul/Sbv166  0.692
2015 Bootsman F, Brouwer RM, Kemner SM, Schnack HG, van der Schot AC, Vonk R, Hillegers MH, Boomsma DI, Hulshoff Pol HE, Nolen WA, Kahn RS, van Haren NE. Contribution of genes and unique environment to cross-sectional and longitudinal measures of subcortical volumes in bipolar disorder. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 26481908 DOI: 10.1016/J.Euroneuro.2015.09.023  0.353
2015 Collin G, van den Heuvel MP, Abramovic L, Vreeker A, de Reus MA, van Haren NE, Boks MP, Ophoff RA, Kahn RS. Brain network analysis reveals affected connectome structure in bipolar I disorder. Human Brain Mapping. PMID 26454006 DOI: 10.1002/Hbm.23017  0.377
2015 van Haren NE, Schnack HG, Koevoets MG, Cahn W, Hulshoff Pol HE, Kahn RS. Trajectories of subcortical volume change in schizophrenia: A 5-year follow-up. Schizophrenia Research. PMID 26439952 DOI: 10.1016/J.Schres.2015.09.027  0.434
2015 Bohlken MM, Brouwer RM, Mandl RC, Hedman AM, van den Heuvel MP, van Haren NE, Kahn RS, Hulshoff Pol HE. Topology of genetic associations between regional gray matter volume and intellectual ability: Evidence for a high capacity network. Neuroimage. 124: 1044-1053. PMID 26424180 DOI: 10.1016/J.Neuroimage.2015.09.046  0.328
2015 Kahn RS, Giannopoulou A. The safety, efficacy and tolerability of Abilify Maintena for the treatment of schizophrenia. Expert Review of Neurotherapeutics. 15: 969-81. PMID 26289486 DOI: 10.1586/14737175.2015.1070670  0.38
2015 Lee SH, Byrne EM, Hultman CM, Kähler A, Vinkhuyzen AA, Ripke S, Andreassen OA, Frisell T, Gusev A, Hu X, Karlsson R, Mantzioris VX, McGrath JJ, Mehta D, Stahl EA, ... ... Kahn RS, et al. New data and an old puzzle: the negative association between schizophrenia and rheumatoid arthritis. International Journal of Epidemiology. PMID 26286434 DOI: 10.1093/Ije/Dyv136  0.359
2015 Heering HD, Koevoets GJ, Koenders L, Machielsen MW, Meijer CJ, Kubota M, de Nijs J, Cahn W, Hulshoff Pol HE, de Haan L, Kahn RS, van Haren NE. Structural MRI Differences between Patients with and without First Rank Symptoms: A Delusion? Frontiers in Psychiatry. 6: 107. PMID 26283974 DOI: 10.3389/Fpsyt.2015.00107  0.373
2015 van Erp TG, Hibar DP, Rasmussen JM, Glahn DC, Pearlson GD, Andreassen OA, Agartz I, Westlye LT, Haukvik UK, Dale AM, Melle I, Hartberg CB, Gruber O, Kraemer B, Zilles D, ... ... Kahn RS, et al. Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium. Molecular Psychiatry. PMID 26283641 DOI: 10.1038/Mp.2015.118  0.674
2015 Toulopoulou T, van Haren N, Zhang X, Sham PC, Cherny SS, Campbell DD, Picchioni M, Murray R, Boomsma DI, Pol HH, Brouwer R, Schnack H, Fañanás L, Sauer H, Nenadic I, ... ... Kahn RS, et al. Reciprocal causation models of cognitive vs volumetric cerebral intermediate phenotypes for schizophrenia in a pan-European twin cohort. Molecular Psychiatry. PMID 26283640 DOI: 10.1038/Mp.2015.117  0.537
2015 Hedman AM, van Haren NE, van Baal GC, Brouwer RM, Brans RG, Schnack HG, Kahn RS, Hulshoff Pol HE. Heritability of cortical thickness changes over time in twin pairs discordant for schizophrenia. Schizophrenia Research. PMID 26215507 DOI: 10.1016/J.Schres.2015.06.021  0.429
2015 Emsley R, Asmal L, Chiliza B, du Plessis S, Carr J, Kidd M, Malhotra AK, Vink M, Kahn RS. Changes in brain regions associated with food-intake regulation, body mass and metabolic profiles during acute antipsychotic treatment in first-episode schizophrenia. Psychiatry Research. PMID 26184461 DOI: 10.1016/J.Pscychresns.2015.06.014  0.678
2015 Rösler L, Rolfs M, Van der Stigchel S, Neggers SF, Cahn W, Kahn RS, Thakkar KN. Failure to use corollary discharge to remap visual target locations is associated with psychotic symptom severity in schizophrenia. Journal of Neurophysiology. jn.00155.2015. PMID 26108951 DOI: 10.1152/Jn.00155.2015  0.325
2015 Kubota M, van Haren NE, Haijma SV, Schnack HG, Cahn W, Hulshoff Pol HE, Kahn RS. Association of IQ Changes and Progressive Brain Changes in Patients With Schizophrenia. Jama Psychiatry. PMID 26083394 DOI: 10.1001/Jamapsychiatry.2015.0712  0.421
2015 van Erp TG, Hibar DP, Rasmussen JM, Glahn DC, Pearlson GD, Andreassen OA, Agartz I, Westlye LT, Haukvik UK, Dale AM, Melle I, Hartberg CB, Gruber O, Kraemer B, Zilles D, ... ... Kahn RS, et al. Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium. Molecular Psychiatry. PMID 26033243 DOI: 10.1038/Mp.2015.63  0.672
2015 Czobor P, Van Dorn RA, Citrome L, Kahn RS, Fleischhacker WW, Volavka J. Treatment adherence in schizophrenia: A patient-level meta-analysis of combined CATIE and EUFEST studies. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 25: 1158-66. PMID 26004980 DOI: 10.1016/J.Euroneuro.2015.04.003  0.39
2015 de Witte LD, Hoffmann C, van Mierlo HC, Titulaer MJ, Kahn RS, Martinez-Martinez P. Absence of N-Methyl-D-Aspartate Receptor IgG Autoantibodies in Schizophrenia: The Importance of Cross-Validation Studies. Jama Psychiatry. 72: 731-3. PMID 25970159 DOI: 10.1001/Jamapsychiatry.2015.0526  0.334
2015 Vreeker A, van Bergen AH, Kahn RS. Cognitive enhancing agents in schizophrenia and bipolar disorder. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 25: 969-1002. PMID 25957798 DOI: 10.1016/J.Euroneuro.2015.04.014  0.402
2015 Pijnenborg GH, Timmerman ME, Derks EM, Fleischhacker WW, Kahn RS, Aleman A. Differential effects of antipsychotic drugs on insight in first episode schizophrenia: Data from the European First-Episode Schizophrenia Trial (EUFEST). European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 25: 808-16. PMID 25907250 DOI: 10.1016/J.Euroneuro.2015.02.012  0.423
2015 Arango C, Kapur S, Kahn RS. Going beyond "trial-and-error" in psychiatric treatments: OPTiMiSE-ing the treatment of first episode of schizophrenia. Schizophrenia Bulletin. 41: 546-8. PMID 25864201 DOI: 10.1093/Schbul/Sbv026  0.37
2015 Zandi T, Havenaar JM, Laan W, Kahn RS, Brink WV. Effects of a culturally sensitive assessment on symptom profiles in native Dutch and Moroccan patients with a first psychosis referral. Transcultural Psychiatry. PMID 25851336 DOI: 10.1177/1363461515577288  0.302
2015 Renes RA, van der Weiden A, Prikken M, Kahn RS, Aarts H, van Haren NE. Abnormalities in the experience of self-agency in schizophrenia: A replication study. Schizophrenia Research. 164: 210-3. PMID 25843918 DOI: 10.1016/J.Schres.2015.03.015  0.349
2015 Svatkova A, Mandl RC, Scheewe TW, Cahn W, Kahn RS, Hulshoff Pol HE. Physical Exercise Keeps the Brain Connected: Biking Increases White Matter Integrity in Patients With Schizophrenia and Healthy Controls. Schizophrenia Bulletin. 41: 869-78. PMID 25829377 DOI: 10.1093/Schbul/Sbv033  0.402
2015 Bossong MG, Mehta MA, van Berckel BN, Howes OD, Kahn RS, Stokes PR. Further human evidence for striatal dopamine release induced by administration of ∆9-tetrahydrocannabinol (THC): selectivity to limbic striatum. Psychopharmacology. 232: 2723-9. PMID 25801289 DOI: 10.1007/S00213-015-3915-0  0.355
2015 Dazzan P, Arango C, Fleischacker W, Galderisi S, Glenthøj B, Leucht S, Meyer-Lindenberg A, Kahn R, Rujescu D, Sommer I, Winter I, McGuire P. Magnetic resonance imaging and the prediction of outcome in first-episode schizophrenia: a review of current evidence and directions for future research. Schizophrenia Bulletin. 41: 574-83. PMID 25800248 DOI: 10.1093/Schbul/Sbv024  0.372
2015 Vorstman JA, Breetvelt EJ, Duijff SN, Eliez S, Schneider M, Jalbrzikowski M, Armando M, Vicari S, Shashi V, Hooper SR, Chow EW, Fung WL, Butcher NJ, Young DA, McDonald-McGinn DM, ... ... Kahn RS, et al. Cognitive decline preceding the onset of psychosis in patients with 22q11.2 deletion syndrome. Jama Psychiatry. 72: 377-85. PMID 25715178 DOI: 10.1001/Jamapsychiatry.2014.2671  0.33
2015 Vink M, Kleerekooper I, van den Wildenberg WP, Kahn RS. Impact of aging on frontostriatal reward processing. Human Brain Mapping. 36: 2305-17. PMID 25704624 DOI: 10.1002/Hbm.22771  0.64
2015 Vinkers CH, Joëls M, Milaneschi Y, Gerritsen L, Kahn RS, Penninx BW, Boks MP. Mineralocorticoid receptor haplotypes sex-dependently moderate depression susceptibility following childhood maltreatment. Psychoneuroendocrinology. 54: 90-102. PMID 25686805 DOI: 10.1016/J.Psyneuen.2015.01.018  0.547
2015 Schirmbeck F, Boyette LL, van der Valk R, Meijer C, Dingemans P, Van R, de Haan L, Kahn RS, de Haan L, van Os J, Wiersma D, Bruggeman R, Cahn W, Meijer C, et al. Relevance of Five-Factor Model personality traits for obsessive-compulsive symptoms in patients with psychotic disorders and their un-affected siblings. Psychiatry Research. 225: 464-70. PMID 25613659 DOI: 10.1016/J.Psychres.2014.11.066  0.338
2015 Hibar DP, Stein JL, Renteria ME, Arias-Vasquez A, Desrivières S, Jahanshad N, Toro R, Wittfeld K, Abramovic L, Andersson M, Aribisala BS, Armstrong NJ, Bernard M, Bohlken MM, Boks MP, ... ... Kahn RS, et al. Common genetic variants influence human subcortical brain structures. Nature. 520: 224-9. PMID 25607358 DOI: 10.1038/Nature14101  0.68
2015 Maat A, van Montfort SJ, de Nijs J, Derks EM, Kahn RS, Linszen DH, van Os J, Wiersma D, Bruggeman R, Cahn W, de Haan L, Krabbendam L, Myin-Germeys I. Emotion processing in schizophrenia is state and trait dependent. Schizophrenia Research. 161: 392-8. PMID 25543332 DOI: 10.1016/J.Schres.2014.11.027  0.386
2015 Mandl RC, Pasternak O, Cahn W, Kubicki M, Kahn RS, Shenton ME, Hulshoff Pol HE. Comparing free water imaging and magnetization transfer measurements in schizophrenia. Schizophrenia Research. 161: 126-32. PMID 25454797 DOI: 10.1016/J.Schres.2014.09.046  0.362
2015 Houtepen LC, Boks MP, Kahn RS, Joëls M, Vinkers CH. Antipsychotic use is associated with a blunted cortisol stress response: a study in euthymic bipolar disorder patients and their unaffected siblings. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 25: 77-84. PMID 25453485 DOI: 10.1016/J.Euroneuro.2014.10.005  0.593
2015 de Leeuw M, Kahn RS, Vink M. Fronto-striatal dysfunction during reward processing in unaffected siblings of schizophrenia patients. Schizophrenia Bulletin. 41: 94-103. PMID 25368371 DOI: 10.1093/Schbul/Sbu153  0.723
2015 Sommer IE, Kahn RS. The contribution of neuroimaging to understanding schizophrenia; past, present, and future. Schizophrenia Bulletin. 41: 1-3. PMID 25347988 DOI: 10.1093/Schbul/Sbu141  0.407
2015 Arango C, Kahn RS. More treatment for those most in need? A foregone conclusion? Schizophrenia Bulletin. 41: 26-7. PMID 25344948 DOI: 10.1093/Schbul/Sbu149  0.329
2015 Kennis M, Rademaker AR, van Rooij SJ, Kahn RS, Geuze E. Resting state functional connectivity of the anterior cingulate cortex in veterans with and without post-traumatic stress disorder. Human Brain Mapping. 36: 99-109. PMID 25137414 DOI: 10.1002/Hbm.22615  0.307
2015 Bootsman F, Brouwer RM, Schnack HG, van Baal GC, van der Schot AC, Vonk R, Hulshoff Pol HE, Nolen WA, Kahn RS, van Haren NE. Genetic and environmental influences on cortical surface area and cortical thickness in bipolar disorder. Psychological Medicine. 45: 193-204. PMID 25065711 DOI: 10.1017/S0033291714001251  0.311
2015 Kahn RS, Sommer IE. The neurobiology and treatment of first-episode schizophrenia. Molecular Psychiatry. 20: 84-97. PMID 25048005 DOI: 10.1038/Mp.2014.66  0.458
2015 van Rooij SJ, Rademaker AR, Kennis M, Vink M, Kahn RS, Geuze E. Neural correlates of trauma-unrelated emotional processing in war veterans with PTSD. Psychological Medicine. 45: 575-87. PMID 25036523 DOI: 10.1017/S0033291714001706  0.596
2015 van Erp TGM, Hibar DP, Rasmussen JM, Glahn DC, Pearlson GD, Andreassen OA, Agartz I, Westlye LT, Haukvik UK, Dale AM, Melle I, Hartberg CB, Gruber O, Kraemer B, Zilles D, ... ... Kahn RS, et al. Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium Molecular Psychiatry. DOI: 10.1038/mp.2015.118  0.329
2015 Hillegers M, De Jong A, Vink M, Pouwels R, Vleeschouwer M, Van Haren N, Kahn R. S.22.01 Clinical and neuro-imaging characteristics of child and adolescent bipolar and schizophrenia offspring European Neuropsychopharmacology. 25: S142. DOI: 10.1016/S0924-977X(15)30101-2  0.67
2015 Pijnenborg G, Timmerman M, Derks E, Fleischhacker W, Kahn R, Aleman A. Do Antipsychotics Affect Insight in Psychosis Differentially? Data From the EUFEST Trial. European Psychiatry. 30: 239. DOI: 10.1016/S0924-9338(15)30194-2  0.399
2015 Cahn W, Bruggeman R, De Haan L, Kahn R, Myin-Germeys I, Van Os J. Long-term Outcome in Schizophrenia: a Six-year Follow-up in over 1000 Patients European Psychiatry. 30: 238. DOI: 10.1016/S0924-9338(15)30193-0  0.403
2014 Sommer IE, Kahn RS. Psychosis susceptibility syndrome: an alternative name for schizophrenia. The Lancet. Psychiatry. 1: 111. PMID 26360567 DOI: 10.1016/S2215-0366(14)70288-3  0.4
2014 Vonk R, van der Schot AC, van Baal GC, van Oel CJ, Nolen WA, Kahn RS. Dermatoglyphics in relation to brain volumes in twins concordant and discordant for bipolar disorder. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 24: 1885-95. PMID 25451699 DOI: 10.1016/J.Euroneuro.2014.09.010  0.345
2014 Toulopoulou T, van Haren N, Zhang X, Sham PC, Cherny SS, Campbell DD, Picchioni M, Murray R, Boomsma DI, Pol HH, Brouwer R, Schnack H, Fañanás L, Sauer H, Nenadic I, ... ... Kahn RS, et al. Reciprocal causation models of cognitive vs volumetric cerebral intermediate phenotypes for schizophrenia in a pan-European twin cohort. Molecular Psychiatry. PMID 25450228 DOI: 10.1038/Mp.2014.152  0.572
2014 Marsman A, Mandl RC, Klomp DW, Bohlken MM, Boer VO, Andreychenko A, Cahn W, Kahn RS, Luijten PR, Hulshoff Pol HE. GABA and glutamate in schizophrenia: a 7 T ¹H-MRS study. Neuroimage. Clinical. 6: 398-407. PMID 25379453 DOI: 10.1016/J.Nicl.2014.10.005  0.366
2014 Stringer S, Kahn RS, de Witte LD, Ophoff RA, Derks EM. Genetic liability for schizophrenia predicts risk of immune disorders. Schizophrenia Research. 159: 347-52. PMID 25266548 DOI: 10.1016/J.Schres.2014.09.004  0.38
2014 Meijer JH, van Harten P, Meijer CJ, Koeter MW, Bruggeman R, Cahn W, Kahn RS, de Haan L. Association between olfactory identification and parkinsonism in patients with non-affective psychosis. Early Intervention in Psychiatry. PMID 25234230 DOI: 10.1111/Eip.12183  0.418
2014 Rybakowski JK, Vansteelandt K, Remlinger-Molenda A, Fleischhacker WW, Kahn RS, Peuskens J. Extrapyramidal symptoms during treatment of first schizophrenia episode: results from EUFEST. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 24: 1500-5. PMID 25085534 DOI: 10.1016/J.Euroneuro.2014.07.001  0.39
2014 van Lutterveld R, van den Heuvel MP, Diederen KM, de Weijer AD, Begemann MJ, Brouwer RM, Daalman K, Blom JD, Kahn RS, Sommer IE. Cortical thickness in individuals with non-clinical and clinical psychotic symptoms. Brain : a Journal of Neurology. 137: 2664-9. PMID 24951640 DOI: 10.1093/Brain/Awu167  0.341
2014 van Rooij SJ, Rademaker AR, Kennis M, Vink M, Kahn RS, Geuze E. Impaired right inferior frontal gyrus response to contextual cues in male veterans with PTSD during response inhibition. Journal of Psychiatry & Neuroscience : Jpn. 39: 330-8. PMID 24886789 DOI: 10.1503/Jpn.130223  0.635
2014 Marques TR, Levine SZ, Reichenberg A, Kahn R, Derks EM, Fleischhacker WW, Rabinowitz J, Kapur S. How antipsychotics impact the different dimensions of Schizophrenia: a test of competing hypotheses. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 24: 1279-88. PMID 24862257 DOI: 10.1016/J.Euroneuro.2014.04.001  0.401
2014 Bohlken MM, Mandl RC, Brouwer RM, van den Heuvel MP, Hedman AM, Kahn RS, Hulshoff Pol HE. Heritability of structural brain network topology: a DTI study of 156 twins. Human Brain Mapping. 35: 5295-305. PMID 24845163 DOI: 10.1002/Hbm.22550  0.311
2014 Brouwer RM, Hedman AM, van Haren NE, Schnack HG, Brans RG, Smit DJ, Kahn RS, Boomsma DI, Hulshoff Pol HE. Heritability of brain volume change and its relation to intelligence. Neuroimage. 100: 676-83. PMID 24816534 DOI: 10.1016/J.Neuroimage.2014.04.072  0.319
2014 Vinkers CH, Joëls M, Milaneschi Y, Kahn RS, Penninx BW, Boks MP. Stress exposure across the life span cumulatively increases depression risk and is moderated by neuroticism. Depression and Anxiety. 31: 737-45. PMID 24753162 DOI: 10.1002/Da.22262  0.537
2014 de Witte L, Tomasik J, Schwarz E, Guest PC, Rahmoune H, Kahn RS, Bahn S. Cytokine alterations in first-episode schizophrenia patients before and after antipsychotic treatment. Schizophrenia Research. 154: 23-9. PMID 24582037 DOI: 10.1016/J.Schres.2014.02.005  0.356
2014 Vink M, Zandbelt BB, Gladwin T, Hillegers M, Hoogendam JM, van den Wildenberg WP, Du Plessis S, Kahn RS. Frontostriatal activity and connectivity increase during proactive inhibition across adolescence and early adulthood. Human Brain Mapping. 35: 4415-27. PMID 24532023 DOI: 10.1002/Hbm.22483  0.801
2014 Vink M, Derks JM, Hoogendam JM, Hillegers M, Kahn RS. Functional differences in emotion processing during adolescence and early adulthood. Neuroimage. 91: 70-6. PMID 24468408 DOI: 10.1016/J.Neuroimage.2014.01.035  0.647
2014 Maat A, Cahn W, Gijsman HJ, Hovens JE, Kahn RS, Aleman A. Open, randomized trial of the effects of aripiprazole versus risperidone on social cognition in schizophrenia. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 24: 575-84. PMID 24418213 DOI: 10.1016/J.Euroneuro.2013.12.009  0.312
2014 Thompson PM, Stein JL, Medland SE, Hibar DP, Vasquez AA, Renteria ME, Toro R, Jahanshad N, Schumann G, Franke B, Wright MJ, Martin NG, Agartz I, Alda M, Alhusaini S, ... ... Kahn RS, et al. The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data. Brain Imaging and Behavior. 8: 153-82. PMID 24399358 DOI: 10.1007/S11682-013-9269-5  0.768
2014 Brouwer RM, van Soelen IL, Swagerman SC, Schnack HG, Ehli EA, Kahn RS, Hulshoff Pol HE, Boomsma DI. Genetic associations between intelligence and cortical thickness emerge at the start of puberty. Human Brain Mapping. 35: 3760-73. PMID 24382822 DOI: 10.1002/Hbm.22435  0.301
2014 Schubart CD, Sommer IE, Fusar-Poli P, de Witte L, Kahn RS, Boks MP. Cannabidiol as a potential treatment for psychosis. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 24: 51-64. PMID 24309088 DOI: 10.1016/J.Euroneuro.2013.11.002  0.326
2014 Collin G, Kahn RS, de Reus MA, Cahn W, van den Heuvel MP. Impaired rich club connectivity in unaffected siblings of schizophrenia patients. Schizophrenia Bulletin. 40: 438-48. PMID 24298172 DOI: 10.1093/Schbul/Sbt162  0.473
2014 Sommer IE, van Westrhenen R, Begemann MJ, de Witte LD, Leucht S, Kahn RS. Efficacy of anti-inflammatory agents to improve symptoms in patients with schizophrenia: an update. Schizophrenia Bulletin. 40: 181-91. PMID 24106335 DOI: 10.1093/Schbul/Sbt139  0.369
2014 Bohlken MM, Brouwer RM, Mandl RC, van Haren NE, Brans RG, van Baal GC, de Geus EJ, Boomsma DI, Kahn RS, Hulshoff Pol HE. Genes contributing to subcortical volumes and intellectual ability implicate the thalamus. Human Brain Mapping. 35: 2632-42. PMID 24038793 DOI: 10.1002/Hbm.22356  0.329
2014 Schnack HG, Nieuwenhuis M, van Haren NE, Abramovic L, Scheewe TW, Brouwer RM, Hulshoff Pol HE, Kahn RS. Can structural MRI aid in clinical classification? A machine learning study in two independent samples of patients with schizophrenia, bipolar disorder and healthy subjects. Neuroimage. 84: 299-306. PMID 24004694 DOI: 10.1016/J.Neuroimage.2013.08.053  0.435
2014 Bramon E, Pirinen M, Strange A, Lin K, Freeman C, Bellenguez C, Su Z, Band G, Pearson R, Vukcevic D, Langford C, Deloukas P, Hunt S, ... ... Kahn RS, et al. A genome-wide association analysis of a broad psychosis phenotype identifies three loci for further investigation. Biological Psychiatry. 75: 386-97. PMID 23871474 DOI: 10.1016/J.Biopsych.2013.03.033  0.404
2014 Luykx JJ, Bakker SC, Lentjes E, Neeleman M, Strengman E, Mentink L, DeYoung J, de Jong S, Sul JH, Eskin E, van Eijk K, van Setten J, Buizer-Voskamp JE, Cantor RM, Lu A, ... ... Kahn RS, et al. Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluid. Molecular Psychiatry. 19: 228-34. PMID 23319000 DOI: 10.1038/Mp.2012.183  0.316
2014 De Leeuw M, Bohlken M, Mandl R, Kahn R, Vink M. P.3.b.022 Fronto–striatal pathways among schizophrenia patients and their unaffected siblings European Neuropsychopharmacology. 24: S504. DOI: 10.1016/S0924-977X(14)70806-5  0.688
2014 Bossong M, Schubart C, Van Hell H, Iseger T, Van Saane W, Jager G, Van Osch P, Jansma J, Kahn R, Boks M, Ramsey N. P.1.i.012 Genetic modulation of acute effects of delta-9-tetrahydrocannabinol (THC) on resting state brain function European Neuropsychopharmacology. 24: S303-S304. DOI: 10.1016/S0924-977X(14)70481-X  0.493
2014 Sommer I, Witte LDD, Westrhenen RV, Begemann M, Kahn RS. S.18.02 Anti-inflammatory strategies in the treatment of schizophrenia European Neuropsychopharmacology. 24. DOI: 10.1016/S0924-977X(14)70183-X  0.343
2014 van Rooij S, Rademaker A, Kennis M, Vink M, Kahn R, Geuze E. P.4.001 Neural correlates of non-trauma related emotional processing in war veterans with posttraumatic stress disorder European Neuropsychopharmacology. 24: S81. DOI: 10.1016/S0924-977X(14)70091-4  0.613
2014 Svátková A, Mandl RC, Scheewe TW, Kahn R, Cahn W, Pol HEH. EPA-1717 – Effects of exercise therapy on white matter integrity in patients with schizophrenia and healthy controls- a longitudinal DTI study European Psychiatry. 29: 1. DOI: 10.1016/S0924-9338(14)78856-X  0.367
2014 Van Lutterveld R, Van den Heuvel M, Diederen K, De Weijer A, Begemann M, Brouwer R, Daalman K, Blom J, Kahn R, Sommer I. EPA-1053 – Cortical thickness in individuals with nonclinical and clinical psychotic symptoms European Psychiatry. 29: 1. DOI: 10.1016/S0924-9338(14)78339-7  0.391
2014 Vinkers C, Houtepen L, Kahn R, Joels M, Boks M. EPA-0848 – Stress reactivity in euthymic bipolar patietns and their unaffected siblings European Psychiatry. 29: 1. DOI: 10.1016/S0924-9338(14)78185-4  0.301
2014 Emsley R, Asmal L, Ciliza B, Plessis Sd, Carr J, Kidd M, Vink M, Kahn R. Poster #T68 BRAIN SYSTEMS REGULATING FOOD-INTAKE AND BODY MASS CHANGES DURING ACUTE ANTIPSYCHOTIC TREATMENT IN FIRST-EPISODE SCHIZOPHRENIA Schizophrenia Research. 153. DOI: 10.1016/S0920-9964(14)70885-0  0.668
2014 Vink M, Pouwels R, Hillegers M, Kahn R. Poster #M72 DIFFERENTIAL DEVELOPMENT OF THE REWARD NETWORK IN ADOLESCENT OFFSPRING OF SCHIZOPHRENIA PATIENTS Schizophrenia Research. 153: S215-S216. DOI: 10.1016/S0920-9964(14)70622-X  0.673
2014 Kubota M, van Haren NE, Cahn W, Kahn R. Poster #M55 DURATION OF ILLNESS ASSOCIATED WITH CORTICAL THICKNESS CHANGE IN SCHIZOPHRENIA: A LONGITUDINAL MRI STUDY Schizophrenia Research. 153: S209. DOI: 10.1016/S0920-9964(14)70605-X  0.39
2014 Bohlken M, Mandl R, Brouwer R, Kahn R, Pol HH. Poster #M47 WHITE MATTER INTEGRITY AS A CANDIDATE ENDOPHENOTYPE FOR SCHIZOPHRENIA Schizophrenia Research. 153: S206. DOI: 10.1016/S0920-9964(14)70597-3  0.374
2014 Pouwels R, Kahn R, Hillegers M, Vink M. Poster #S106 IMPAIRED DEVELOPMENT OF BRAIN ACTIVATION UNDERLYING AFFECTIVE PROCESSING IN ADOLESCENTS AT FAMILIAL RISK FOR BIPOLAR DISORDER OR SCHIZOPHRENIA Schizophrenia Research. 153: S127. DOI: 10.1016/S0920-9964(14)70385-8  0.695
2014 van Haren NE, Haijma S, Cahn W, Kahn R. Poster #S71 CHANGE IN INTELLIGENCE IS ASSOCIATED WITH PROGRESSIVE GRAY MATTER LOSS IN THE EARLY YEARS OF SCHIZOPHRENIA Schizophrenia Research. 153: S114. DOI: 10.1016/S0920-9964(14)70350-0  0.384
2014 Schnack HG, Nieuwenhuis M, Haren NEMv, Cahn W, Kahn R, Pol HH. Poster #S65 CLASSIFICATION OF TWINS DISCORDANT FOR SCHIZOPHRENIA AND HEALTHY TWINS BASED ON THEIR STRUCTURAL MRI SCANS Schizophrenia Research. 153. DOI: 10.1016/S0920-9964(14)70344-5  0.384
2014 Maat A, Haren NEMv, Bartholomeusz C, Kahn R, Cahn W. Poster #S57 EMOTION RECOGNITION AND THEORY OF MIND ARE RELATED TO GRAY MATTER VOLUME OF THE PREFRONTAL CORTEX IN SCHIZOPHRENIA Schizophrenia Research. 153. DOI: 10.1016/S0920-9964(14)70336-6  0.359
2014 Williams JB, Kane JM, Kahn RS. SCHIZOPHRENIA RESEARCH: THE CHALLENGE OF MEASUREMENT VARIABILITY Schizophrenia Research. 153: S86. DOI: 10.1016/S0920-9964(14)70275-0  0.375
2014 Vorstman JAS, Kahn R. Twenty Years Of Research On The 22Q11.2 Deletion Syndrome And Schizophrenia: What Have We Learned So Far? Schizophrenia Research. 153. DOI: 10.1016/S0920-9964(14)70243-9  0.319
2014 de Leeuw M, Kahn R, Vink M. 5:30 PM REWARD PROCESSING IN UNAFFECTED SIBLINGS OF SCHIZOPHRENIA PATIENTS: AN FMRI STUDY Schizophrenia Research. 153: S64. DOI: 10.1016/S0920-9964(14)70206-3  0.706
2014 Marsman A, Mandl R, Klomp D, Bohlken M, Boer V, Andreychenko A, Cahn W, Kahn R, Luijten P, Pol HH. 5:15 Pm Gaba And Glutamate In Schizophrenia: A 7T 1H-Mrs Study Schizophrenia Research. 153. DOI: 10.1016/S0920-9964(14)70179-3  0.314
2014 Heuvel Mvd, Collin G, Hillegers M, Reus Md, Kahn W, Kahn R. 5:00 Pm Emerging Evidence Of Affected Anatomical Rich Club Hub Structure In Schizophrenia Patients, Their Healthy Siblings And Their Non-Affected Young Offspring Schizophrenia Research. 153. DOI: 10.1016/S0920-9964(14)70178-1  0.415
2014 Kahn RS, Cahn W, van Haren N, Haijma S, Hulshoff H. LONG TERM OUTCOME IN SCHIZOPHRENIA: A 6 YEAR FOLLOW UP IN OVER 1000 PATIENTS Schizophrenia Research. 153: S49-S50. DOI: 10.1016/S0920-9964(14)70163-X  0.358
2014 Kahn RS, Vink M, Hillegers M, Vleeschouwer M. ABNORMALITIES IN REWARD PROCESSING IN OFFSPRING OF SCHIZOPHRENIA PATIENTS: FRONTAL-STRIATAL ABNORMALITIES AS A HIGH-RISK PHENOTYPE Schizophrenia Research. 153: S38. DOI: 10.1016/S0920-9964(14)70125-2  0.7
2014 Siever LJ, Kahn RS. NEW VISTAS IN DOPAMINE RECEPTOR RESEARCH: IMPLICATIONS FOR NOVEL THERAPIES IN SCHIZOPHRENIA Schizophrenia Research. 153: S5. DOI: 10.1016/S0920-9964(14)70016-7  0.348
2014 DeLisi L, Kahn R. Impact Of Genomics And Connectomics Approaches On Schizophrenia Research Schizophrenia Research. 153. DOI: 10.1016/S0920-9964(14)70004-0  0.345
2014 Kahn R. Social neuroscience in psychiatry: Of obvious relevance World Psychiatry. 13: 147-148. DOI: 10.1002/Wps.20124  0.408
2013 Jansma JM, van Raalten TR, Boessen R, Neggers SF, Jacobs RH, Kahn RS, Ramsey NF. fMRI guided rTMS evidence for reduced left prefrontal involvement after task practice. Plos One. 8: e80256. PMID 24376494 DOI: 10.1371/Journal.Pone.0080256  0.526
2013 Hoogendam JM, Kahn RS, Hillegers MH, van Buuren M, Vink M. Different developmental trajectories for anticipation and receipt of reward during adolescence. Developmental Cognitive Neuroscience. 6: 113-24. PMID 24055865 DOI: 10.1016/J.Dcn.2013.08.004  0.633
2013 de Leeuw M, Kahn RS, Zandbelt BB, Widschwendter CG, Vink M. Working memory and default mode network abnormalities in unaffected siblings of schizophrenia patients. Schizophrenia Research. 150: 555-62. PMID 24051015 DOI: 10.1016/J.Schres.2013.08.016  0.815
2013 Marder SR, Alphs L, Anghelescu IG, Arango C, Barnes TR, Caers I, Daniel DG, Dunayevich E, Fleischhacker WW, Garibaldi G, Green MF, Harvey PD, Kahn RS, Kane JM, Keefe RS, et al. Issues and perspectives in designing clinical trials for negative symptoms in schizophrenia. Schizophrenia Research. 150: 328-33. PMID 24028744 DOI: 10.1016/J.Schres.2013.07.058  0.309
2013 Bossong MG, Jansma JM, van Hell HH, Jager G, Kahn RS, Ramsey NF. Default mode network in the effects of Δ9-Tetrahydrocannabinol (THC) on human executive function. Plos One. 8: e70074. PMID 23936144 DOI: 10.1371/Journal.Pone.0070074  0.566
2013 Lee SH, Ripke S, Neale BM, Faraone SV, Purcell SM, Perlis RH, Mowry BJ, Thapar A, Goddard ME, Witte JS, Absher D, Agartz I, Akil H, Amin F, ... ... Kahn RS, et al. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nature Genetics. 45: 984-94. PMID 23933821 DOI: 10.1038/Ng.2711  0.321
2013 Bossong MG, van Hell HH, Jager G, Kahn RS, Ramsey NF, Jansma JM. The endocannabinoid system and emotional processing: a pharmacological fMRI study with ∆9-tetrahydrocannabinol. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 1687-97. PMID 23928295 DOI: 10.1016/J.Euroneuro.2013.06.009  0.511
2013 Kahn RS, Keefe RS. Schizophrenia is a cognitive illness: time for a change in focus. Jama Psychiatry. 70: 1107-12. PMID 23925787 DOI: 10.1001/Jamapsychiatry.2013.155  0.375
2013 Mandl RC, Brouwer RM, Cahn W, Kahn RS, Hulshoff Pol HE. Family-wise automatic classification in schizophrenia. Schizophrenia Research. 149: 108-11. PMID 23876264 DOI: 10.1016/J.Schres.2013.07.002  0.31
2013 Malchow B, Reich-Erkelenz D, Oertel-Knöchel V, Keller K, Hasan A, Schmitt A, Scheewe TW, Cahn W, Kahn RS, Falkai P. The effects of physical exercise in schizophrenia and affective disorders. European Archives of Psychiatry and Clinical Neuroscience. 263: 451-67. PMID 23873090 DOI: 10.1007/S00406-013-0423-2  0.342
2013 Brouwer A, Luykx JJ, van Boxmeer L, Bakker SC, Kahn RS. NMDA-receptor coagonists in serum, plasma, and cerebrospinal fluid of schizophrenia patients: a meta-analysis of case-control studies. Neuroscience and Biobehavioral Reviews. 37: 1587-96. PMID 23792047 DOI: 10.1016/J.Neubiorev.2013.06.007  0.334
2013 van den Heuvel MP, Sporns O, Collin G, Scheewe T, Mandl RC, Cahn W, Goñi J, Hulshoff Pol HE, Kahn RS. Abnormal rich club organization and functional brain dynamics in schizophrenia. Jama Psychiatry. 70: 783-92. PMID 23739835 DOI: 10.1001/Jamapsychiatry.2013.1328  0.42
2013 Kahn RS. Finally: a focus on cognition in schizophrenia. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 779-80. PMID 23684112 DOI: 10.1016/J.Euroneuro.2013.04.005  0.382
2013 Riecher-Rössler A, Rybakowski JK, Pflueger MO, Beyrau R, Kahn RS, Malik P, Fleischhacker WW. Hyperprolactinemia in antipsychotic-naive patients with first-episode psychosis. Psychological Medicine. 43: 2571-82. PMID 23590895 DOI: 10.1017/S0033291713000226  0.387
2013 Wobrock T, Falkai P, Schneider-Axmann T, Hasan A, Galderisi S, Davidson M, Kahn RS, Derks EM, Boter H, Rybakowski JK, Libiger J, Dollfus S, López-Ibor JJ, Peuskens J, Hranov LG, et al. Comorbid substance abuse in first-episode schizophrenia: effects on cognition and psychopathology in the EUFEST study. Schizophrenia Research. 147: 132-9. PMID 23537477 DOI: 10.1016/J.Schres.2013.03.001  0.436
2013 Hedman AM, van Haren NE, van Baal CG, Kahn RS, Hulshoff Pol HE. IQ change over time in schizophrenia and healthy individuals: a meta-analysis. Schizophrenia Research. 146: 201-8. PMID 23490758 DOI: 10.1016/J.Schres.2013.01.027  0.443
2013 Diederen KM, Charbonnier L, Neggers SF, van Lutterveld R, Daalman K, Slotema CW, Kahn RS, Sommer IE. Reproducibility of brain activation during auditory verbal hallucinations. Schizophrenia Research. 146: 320-5. PMID 23465967 DOI: 10.1016/J.Schres.2013.01.025  0.303
2013 Jansma JM, van Hell HH, Vanderschuren LJ, Bossong MG, Jager G, Kahn RS, Ramsey NF. THC reduces the anticipatory nucleus accumbens response to reward in subjects with a nicotine addiction. Translational Psychiatry. 3: e234. PMID 23443360 DOI: 10.1038/Tp.2013.6  0.491
2013 Czobor P, Volavka J, Derks EM, Bitter I, Libiger J, Kahn RS, Fleischhacker WW. Insight and hostility as predictors and correlates of nonadherence in the European First Episode Schizophrenia Trial. Journal of Clinical Psychopharmacology. 33: 258-61. PMID 23422388 DOI: 10.1097/Jcp.0B013E3182856886  0.401
2013 van Scheltinga AF, Bakker SC, van Haren NE, Derks EM, Buizer-Voskamp JE, Cahn W, Ripke S, Ophoff RA, Kahn RS. Schizophrenia genetic variants are not associated with intelligence. Psychological Medicine. 43: 2563-70. PMID 23410598 DOI: 10.1017/S0033291713000196  0.44
2013 Terwisscha van Scheltinga AF, Bakker SC, Kahn RS, Kas MJ. Fibroblast growth factors in neurodevelopment and psychopathology. The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry. 19: 479-94. PMID 23343917 DOI: 10.1177/1073858412472399  0.324
2013 Fleischhacker WW, Siu CO, Bodén R, Pappadopulos E, Karayal ON, Kahn RS. Metabolic risk factors in first-episode schizophrenia: baseline prevalence and course analysed from the European First-Episode Schizophrenia Trial. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 16: 987-95. PMID 23253821 DOI: 10.1017/S1461145712001241  0.38
2013 van Welie H, Derks EM, Verweij KH, de Valk HW, Kahn RS, Cahn W. The prevalence of diabetes mellitus is increased in relatives of patients with a non-affective psychotic disorder. Schizophrenia Research. 143: 354-7. PMID 23245702 DOI: 10.1016/J.Schres.2012.11.011  0.348
2013 Diederen KM, Neggers SF, de Weijer AD, van Lutterveld R, Daalman K, Eickhoff SB, Clos M, Kahn RS, Sommer IE. Aberrant resting-state connectivity in non-psychotic individuals with auditory hallucinations. Psychological Medicine. 43: 1685-96. PMID 23199762 DOI: 10.1017/S0033291712002541  0.366
2013 Vorstman JA, Anney RJ, Derks EM, Gallagher L, Gill M, de Jonge MV, van Engeland H, Kahn RS, Ophoff RA. No evidence that common genetic risk variation is shared between schizophrenia and autism. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 162: 55-60. PMID 23193033 DOI: 10.1002/Ajmg.B.32121  0.41
2013 Renes RA, Vermeulen L, Kahn RS, Aarts H, van Haren NE. Abnormalities in the establishment of feeling of self-agency in schizophrenia. Schizophrenia Research. 143: 50-4. PMID 23178108 DOI: 10.1016/J.Schres.2012.10.024  0.363
2013 Scheewe TW, Backx FJ, Takken T, Jörg F, van Strater AC, Kroes AG, Kahn RS, Cahn W. Exercise therapy improves mental and physical health in schizophrenia: a randomised controlled trial. Acta Psychiatrica Scandinavica. 127: 464-73. PMID 23106093 DOI: 10.1111/Acps.12029  0.322
2013 Zandbelt BB, Bloemendaal M, Hoogendam JM, Kahn RS, Vink M. Transcranial magnetic stimulation and functional MRI reveal cortical and subcortical interactions during stop-signal response inhibition. Journal of Cognitive Neuroscience. 25: 157-74. PMID 23066733 DOI: 10.1162/Jocn_A_00309  0.78
2013 Haijma SV, Van Haren N, Cahn W, Koolschijn PC, Hulshoff Pol HE, Kahn RS. Brain volumes in schizophrenia: a meta-analysis in over 18 000 subjects. Schizophrenia Bulletin. 39: 1129-38. PMID 23042112 DOI: 10.1093/Schbul/Sbs118  0.428
2013 Terwisscha van Scheltinga AF, Bakker SC, van Haren NE, Derks EM, Buizer-Voskamp JE, Boos HB, Cahn W, Hulshoff Pol HE, Ripke S, Ophoff RA, Kahn RS. Genetic schizophrenia risk variants jointly modulate total brain and white matter volume. Biological Psychiatry. 73: 525-31. PMID 23039932 DOI: 10.1016/J.Biopsych.2012.08.017  0.429
2013 Collin G, de Reus MA, Cahn W, Hulshoff Pol HE, Kahn RS, van den Heuvel MP. Disturbed grey matter coupling in schizophrenia. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 46-54. PMID 23036782 DOI: 10.1016/J.Euroneuro.2012.09.001  0.427
2013 Van Haren NE, Cahn W, Hulshoff Pol HE, Kahn RS. Confounders of excessive brain volume loss in schizophrenia. Neuroscience and Biobehavioral Reviews. 37: 2418-23. PMID 23000300 DOI: 10.1016/J.Neubiorev.2012.09.006  0.424
2013 Scheewe TW, van Haren NE, Sarkisyan G, Schnack HG, Brouwer RM, de Glint M, Hulshoff Pol HE, Backx FJ, Kahn RS, Cahn W. Exercise therapy, cardiorespiratory fitness and their effect on brain volumes: a randomised controlled trial in patients with schizophrenia and healthy controls. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 675-85. PMID 22981376 DOI: 10.1016/J.Euroneuro.2012.08.008  0.39
2013 Boos HB, Mandl RC, van Haren NE, Cahn W, van Baal GC, Kahn RS, Hulshoff Pol HE. Tract-based diffusion tensor imaging in patients with schizophrenia and their non-psychotic siblings. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 295-304. PMID 22841128 DOI: 10.1016/J.Euroneuro.2012.05.015  0.439
2013 van den Heuvel MP, van Soelen IL, Stam CJ, Kahn RS, Boomsma DI, Hulshoff Pol HE. Genetic control of functional brain network efficiency in children. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 19-23. PMID 22819192 DOI: 10.1016/J.Euroneuro.2012.06.007  0.32
2013 van Liempt S, Arends J, Cluitmans PJ, Westenberg HG, Kahn RS, Vermetten E. Sympathetic activity and hypothalamo-pituitary-adrenal axis activity during sleep in post-traumatic stress disorder: a study assessing polysomnography with simultaneous blood sampling. Psychoneuroendocrinology. 38: 155-65. PMID 22776420 DOI: 10.1016/J.Psyneuen.2012.05.015  0.527
2013 Galderisi S, Mucci A, Bitter I, Libiger J, Bucci P, Fleischhacker WW, Kahn RS. Persistent negative symptoms in first episode patients with schizophrenia: results from the European First Episode Schizophrenia Trial. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 196-204. PMID 22647933 DOI: 10.1016/J.Euroneuro.2012.04.019  0.383
2013 Mandl RC, Rais M, van Baal GC, van Haren NE, Cahn W, Kahn RS, Hulshoff Pol HE. Altered white matter connectivity in never-medicated patients with schizophrenia. Human Brain Mapping. 34: 2353-65. PMID 22461372 DOI: 10.1002/Hbm.22075  0.393
2013 Sommer IE, de Kort GA, Meijering AL, Dazzan P, Hulshoff Pol HE, Kahn RS, van Haren NE. How frequent are radiological abnormalities in patients with psychosis? A review of 1379 MRI scans. Schizophrenia Bulletin. 39: 815-9. PMID 22416264 DOI: 10.1093/Schbul/Sbs037  0.35
2013 Zandbelt BB, Bloemendaal M, Neggers SF, Kahn RS, Vink M. Expectations and violations: delineating the neural network of proactive inhibitory control. Human Brain Mapping. 34: 2015-24. PMID 22359406 DOI: 10.1002/Hbm.22047  0.775
2013 Howes OD, Shotbolt P, Bloomfield M, Daalman K, Demjaha A, Diederen KM, Ibrahim K, Kim E, McGuire P, Kahn RS, Sommer IE. Dopaminergic function in the psychosis spectrum: an [18F]-DOPA imaging study in healthy individuals with auditory hallucinations. Schizophrenia Bulletin. 39: 807-14. PMID 22282457 DOI: 10.1093/Schbul/Sbr195  0.318
2013 van Soelen IL, Brouwer RM, van Baal GC, Schnack HG, Peper JS, Chen L, Kahn RS, Boomsma DI, Hulshoff Pol HE. Heritability of volumetric brain changes and height in children entering puberty. Human Brain Mapping. 34: 713-25. PMID 22140022 DOI: 10.1002/Hbm.21468  0.303
2013 de Weijer AD, Neggers SF, Diederen KM, Mandl RC, Kahn RS, Hulshoff Pol HE, Sommer IE. Aberrations in the arcuate fasciculus are associated with auditory verbal hallucinations in psychotic and in non-psychotic individuals. Human Brain Mapping. 34: 626-34. PMID 22109992 DOI: 10.1002/Hbm.21463  0.412
2013 Marsman A, van den Heuvel MP, Klomp DW, Kahn RS, Luijten PR, Hulshoff Pol HE. Glutamate in schizophrenia: a focused review and meta-analysis of ¹H-MRS studies. Schizophrenia Bulletin. 39: 120-9. PMID 21746807 DOI: 10.1093/Schbul/Sbr069  0.423
2013 Maat A, Cahn W, Gijsman HJ, Hovens JE, Kahn RS, Aleman A. Poster sessionsP.1.g. Basic and clinical neuroscience – NeuropharmacologyP.1.g.024 Open, randomized trial of the effects of aripiprazole versus risperidone on social cognition in schizophrenia European Neuropsychopharmacology. 23. DOI: 10.1016/S0924-977X(13)70311-0  0.304
2013 De Leeuw M, Kahn R, Vink M. S.07.07 Reward processing in unaffected siblings of schizophrenia patients: a functional magnetic resonance imaging study European Neuropsychopharmacology. 23: S122. DOI: 10.1016/S0924-977X(13)70151-2  0.685
2013 Doef TFvd, Yaqub M, Bossong MG, Boellaard R, Windhorst AD, Lammertsma AA, Kahn RS, Berckel BNMv. P.4.032 Neuroinflammation in temporal cortex in schizophrenia patients European Neuropsychopharmacology. 23. DOI: 10.1016/S0924-977X(13)70106-8  0.404
2013 de Leeuw M, Vink M, Kahn R. P.4.006 Reward processing in unaffected siblings of schizophrenia patients: a functional magnetic resonance imaging study European Neuropsychopharmacology. 23: S72-S73. DOI: 10.1016/S0924-977X(13)70081-6  0.61
2012 van Buuren M, Vink M, Kahn RS. Default-mode network dysfunction and self-referential processing in healthy siblings of schizophrenia patients. Schizophrenia Research. 142: 237-43. PMID 23099059 DOI: 10.1016/J.Schres.2012.09.017  0.705
2012 van der Kemp WJ, Klomp DW, Kahn RS, Luijten PR, Hulshoff Pol HE. A meta-analysis of the polyunsaturated fatty acid composition of erythrocyte membranes in schizophrenia. Schizophrenia Research. 141: 153-61. PMID 22981812 DOI: 10.1016/J.Schres.2012.08.014  0.391
2012 He Y, Yu Z, Giegling I, Xie L, Hartmann AM, Prehn C, Adamski J, Kahn R, Li Y, Illig T, Wang-Sattler R, Rujescu D. Schizophrenia shows a unique metabolomics signature in plasma Translational Psychiatry. 2. PMID 22892715 DOI: 10.1038/Tp.2012.76  0.426
2012 van Soelen IL, Brouwer RM, Peper JS, van Leeuwen M, Koenis MM, van Beijsterveldt TC, Swagerman SC, Kahn RS, Hulshoff Pol HE, Boomsma DI. Brain SCALE: brain structure and cognition: an adolescent longitudinal twin study into the genetic etiology of individual differences. Twin Research and Human Genetics : the Official Journal of the International Society For Twin Studies. 15: 453-67. PMID 22856378 DOI: 10.1017/Thg.2012.4  0.318
2012 van Lutterveld R, Hillebrand A, Diederen KM, Daalman K, Kahn RS, Stam CJ, Sommer IE. Oscillatory cortical network involved in auditory verbal hallucinations in schizophrenia. Plos One. 7: e41149. PMID 22844436 DOI: 10.1371/Journal.Pone.0041149  0.399
2012 Geyer MA, Olivier B, Joëls M, Kahn RS. From antipsychotic to anti-schizophrenia drugs: role of animal models. Trends in Pharmacological Sciences. 33: 515-21. PMID 22810174 DOI: 10.1016/J.Tips.2012.06.006  0.377
2012 de Jong S, Boks MP, Fuller TF, Strengman E, Janson E, de Kovel CG, Ori AP, Vi N, Mulder F, Blom JD, Glenthøj B, Schubart CD, Cahn W, Kahn RS, Horvath S, et al. A gene co-expression network in whole blood of schizophrenia patients is independent of antipsychotic-use and enriched for brain-expressed genes. Plos One. 7: e39498. PMID 22761806 DOI: 10.1371/Journal.Pone.0039498  0.407
2012 Derks EM, Vorstman JA, Ripke S, Kahn RS, Ophoff RA. Investigation of the genetic association between quantitative measures of psychosis and schizophrenia: a polygenic risk score analysis. Plos One. 7: e37852. PMID 22761660 DOI: 10.1371/Journal.Pone.0037852  0.414
2012 Hedman AM, van Haren NE, van Baal GC, Brans RG, Hijman R, Kahn RS, Hulshoff Pol HE. Is there change in intelligence quotient in chronically ill schizophrenia patients? A longitudinal study in twins discordant for schizophrenia. Psychological Medicine. 42: 2535-41. PMID 22717138 DOI: 10.1017/S0033291712000694  0.433
2012 Rybakowski JK, Vansteelandt K, Szafranski T, Thys E, Jarema M, Wolfgang Fleischhacker W, Kahn RS, Peuskens J. Treatment of depression in first episode of schizophrenia: results from EUFEST. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 22: 875-82. PMID 22627166 DOI: 10.1016/J.Euroneuro.2012.04.001  0.353
2012 Terwisscha van Scheltinga A, Bakker S, van Haren N, Buizer-Voskamp J, Boos H, Vorstman J, Cahn W, Hulshoff Pol H, Ophoff R, Kahn R. Association study of copy number variants with brain volume in schizophrenia patients and healthy controls. Psychiatry Research. 200: 1011-3. PMID 22551941 DOI: 10.1016/J.Psychres.2012.04.007  0.454
2012 Fleischhacker WW, Derks E, Kahn RS. Interpreting treatment trials in schizophrenia patients: lessons learned from EUFEST. Schizophrenia Research. 138: 39-40. PMID 22542244 DOI: 10.1016/J.Schres.2012.03.027  0.348
2012 Collin G, Derks EM, van Haren NE, Schnack HG, Hulshoff Pol HE, Kahn RS, Cahn W. Symptom dimensions are associated with progressive brain volume changes in schizophrenia. Schizophrenia Research. 138: 171-6. PMID 22534419 DOI: 10.1016/J.Schres.2012.03.036  0.432
2012 Scheewe TW, Takken T, Kahn RS, Cahn W, Backx FJ. Effects of exercise therapy on cardiorespiratory fitness in patients with schizophrenia. Medicine and Science in Sports and Exercise. 44: 1834-42. PMID 22525773 DOI: 10.1249/Mss.0B013E318258E120  0.323
2012 Nieuwenhuis M, van Haren NE, Hulshoff Pol HE, Cahn W, Kahn RS, Schnack HG. Classification of schizophrenia patients and healthy controls from structural MRI scans in two large independent samples. Neuroimage. 61: 606-12. PMID 22507227 DOI: 10.1016/J.Neuroimage.2012.03.079  0.386
2012 Stein JL, Medland SE, Vasquez AA, Hibar DP, Senstad RE, Winkler AM, Toro R, Appel K, Bartecek R, Bergmann Ø, Bernard M, Brown AA, Cannon DM, Chakravarty MM, Christoforou A, ... ... Kahn RS, et al. Identification of common variants associated with human hippocampal and intracranial volumes. Nature Genetics. 44: 552-61. PMID 22504417 DOI: 10.1038/Ng.2250  0.765
2012 Hulshoff Pol HE, van Baal GC, Schnack HG, Brans RG, van der Schot AC, Brouwer RM, van Haren NE, Lepage C, Collins DL, Evans AC, Boomsma DI, Nolen W, Kahn RS. Overlapping and segregating structural brain abnormalities in twins with schizophrenia or bipolar disorder. Archives of General Psychiatry. 69: 349-59. PMID 22474104 DOI: 10.1001/Archgenpsychiatry.2011.1615  0.459
2012 de Jong S, van Eijk KR, Zeegers DW, Strengman E, Janson E, Veldink JH, van den Berg LH, Cahn W, Kahn RS, Boks MP, Ophoff RA. Expression QTL analysis of top loci from GWAS meta-analysis highlights additional schizophrenia candidate genes. European Journal of Human Genetics : Ejhg. 20: 1004-8. PMID 22433715 DOI: 10.1038/Ejhg.2012.38  0.41
2012 Dollfus S, Alary M, Razafimandimby A, Prelipceanu D, Rybakowski JK, Davidson M, Galderisi S, Libiger J, Hranov LG, Hummer M, Boter H, Peuskens J, Kahn RS, Fleischhacker WW. Familial sinistrality and handedness in patients with first episode schizophrenia: the EUFEST study. Laterality. 17: 217-24. PMID 22385143 DOI: 10.1080/1357650X.2011.558510  0.405
2012 Rais M, Cahn W, Schnack HG, Hulshoff Pol HE, Kahn RS, van Haren NE. Brain volume reductions in medication-naive patients with schizophrenia in relation to intelligence quotient. Psychological Medicine. 42: 1847-56. PMID 22357376 DOI: 10.1017/S0033291712000098  0.416
2012 van Haren NE, Rijsdijk F, Schnack HG, Picchioni MM, Toulopoulou T, Weisbrod M, Sauer H, van Erp TG, Cannon TD, Huttunen MO, Boomsma DI, Hulshoff Pol HE, Murray RM, Kahn RS. The genetic and environmental determinants of the association between brain abnormalities and schizophrenia: the schizophrenia twins and relatives consortium. Biological Psychiatry. 71: 915-21. PMID 22341827 DOI: 10.1016/J.Biopsych.2012.01.010  0.718
2012 Bossong MG, Jansma JM, van Hell HH, Jager G, Oudman E, Saliasi E, Kahn RS, Ramsey NF. Effects of δ9-tetrahydrocannabinol on human working memory function. Biological Psychiatry. 71: 693-9. PMID 22341370 DOI: 10.1016/J.Biopsych.2012.01.008  0.605
2012 van Dijk D, Koeter MW, Hijman R, Kahn RS, van den Brink W. Effect of cannabis use on the course of schizophrenia in male patients: a prospective cohort study. Schizophrenia Research. 137: 50-7. PMID 22313726 DOI: 10.1016/J.Schres.2012.01.016  0.414
2012 Luykx JJ, Bakker SC, Lentjes E, Boks MP, van Geloven N, Eijkemans MJ, Janson E, Strengman E, de Lepper AM, Westenberg H, Klopper KE, Hoorn HJ, Gelissen HP, Jordan J, Tolenaar NM, ... ... Kahn RS, et al. Season of sampling and season of birth influence serotonin metabolite levels in human cerebrospinal fluid. Plos One. 7: e30497. PMID 22312427 DOI: 10.1371/Journal.Pone.0030497  0.542
2012 Aukes MF, Laan W, Termorshuizen F, Buizer-Voskamp JE, Hennekam EA, Smeets HM, Ophoff RA, Boks MP, Kahn RS. Familial clustering of schizophrenia, bipolar disorder, and major depressive disorder. Genetics in Medicine : Official Journal of the American College of Medical Genetics. 14: 338-41. PMID 22241106 DOI: 10.1016/Gim.2011.16  0.339
2012 Sommer IE, de Witte L, Begemann M, Kahn RS. Nonsteroidal anti-inflammatory drugs in schizophrenia: ready for practice or a good start? A meta-analysis. The Journal of Clinical Psychiatry. 73: 414-9. PMID 22225599 DOI: 10.4088/Jcp.10R06823  0.415
2012 Vonk R, van der Schot AC, van Baal GC, van Oel CJ, Nolen WA, Kahn RS. Premorbid school performance in twins concordant and discordant for bipolar disorder. Journal of Affective Disorders. 136: 294-303. PMID 22166398 DOI: 10.1016/J.Jad.2011.11.034  0.31
2012 Landolt K, Rössler W, Burns T, Ajdacic-Gross V, Galderisi S, Libiger J, Naber D, Derks EM, Kahn RS, Fleischhacker WW. Unmet needs in patients with first-episode schizophrenia: a longitudinal perspective. Psychological Medicine. 42: 1461-73. PMID 22099529 DOI: 10.1017/S0033291711002406  0.377
2012 Bossong MG, Jager G, van Hell HH, Zuurman L, Jansma JM, Mehta MA, van Gerven JM, Kahn RS, Ramsey NF. Effects of Δ9-tetrahydrocannabinol administration on human encoding and recall memory function: a pharmacological FMRI study. Journal of Cognitive Neuroscience. 24: 588-99. PMID 22066583 DOI: 10.1162/Jocn_A_00156  0.523
2012 van Hell HH, Jager G, Bossong MG, Brouwer A, Jansma JM, Zuurman L, van Gerven J, Kahn RS, Ramsey NF. Involvement of the endocannabinoid system in reward processing in the human brain. Psychopharmacology. 219: 981-90. PMID 21822593 DOI: 10.1007/S00213-011-2428-8  0.527
2012 Machielsen M, Beduin AS, Dekker N, Kahn RS, Linszen DH, van Os J, Wiersma D, Bruggeman R, Cahn W, de Haan L, Krabbendam L, Myin-Germeys I. Differences in craving for cannabis between schizophrenia patients using risperidone, olanzapine or clozapine. Journal of Psychopharmacology (Oxford, England). 26: 189-95. PMID 21768161 DOI: 10.1177/0269881111408957  0.337
2012 van Rijn S, Swaab H, Baas D, de Haan E, Kahn RS, Aleman A. Neural systems for social cognition in Klinefelter syndrome (47,XXY): evidence from fMRI. Social Cognitive and Affective Neuroscience. 7: 689-97. PMID 21737434 DOI: 10.1093/Scan/Nsr041  0.329
2012 Klomp A, Koolschijn PC, Hulshoff Pol HE, Kahn RS, Haren NE. Hypothalamus and pituitary volume in schizophrenia: a structural MRI study. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 15: 281-8. PMID 21733239 DOI: 10.1017/S1461145711000794  0.411
2012 van Haren NE, Cahn W, Hulshoff Pol HE, Kahn RS. The course of brain abnormalities in schizophrenia: can we slow the progression? Journal of Psychopharmacology (Oxford, England). 26: 8-14. PMID 21730018 DOI: 10.1177/0269881111408964  0.428
2012 Diederen KM, Daalman K, de Weijer AD, Neggers SF, van Gastel W, Blom JD, Kahn RS, Sommer IE. Auditory hallucinations elicit similar brain activation in psychotic and nonpsychotic individuals. Schizophrenia Bulletin. 38: 1074-82. PMID 21527413 DOI: 10.1093/Schbul/Sbr033  0.395
2012 Boos HB, Cahn W, van Haren NE, Derks EM, Brouwer RM, Schnack HG, Hulshoff Pol HE, Kahn RS. Focal and global brain measurements in siblings of patients with schizophrenia. Schizophrenia Bulletin. 38: 814-25. PMID 21242319 DOI: 10.1093/Schbul/Sbq147  0.461
2012 Ziermans TB, Schothorst PF, Schnack HG, Koolschijn PC, Kahn RS, van Engeland H, Durston S. Progressive structural brain changes during development of psychosis. Schizophrenia Bulletin. 38: 519-30. PMID 20929968 DOI: 10.1093/Schbul/Sbq113  0.375
2012 van Venrooij JA, Fluitman SB, Lijmer JG, Kavelaars A, Heijnen CJ, Westenberg HG, Kahn RS, Gispen-de Wied CC. Impaired neuroendocrine and immune response to acute stress in medication-naive patients with a first episode of psychosis. Schizophrenia Bulletin. 38: 272-9. PMID 20558533 DOI: 10.1093/Schbul/Sbq062  0.589
2012 Leeuw Md, Vink M, Kahn RS. Reward processing in unaffected siblings of schizophrenia patients: an fMRI study F1000research. 3. DOI: 10.7490/F1000Research.1092030.1  0.699
2012 van Dijk D, Koeter MW, Hijman R, Kahn RS, van den Brink W. Poster #252 EFFECT OF CANNABIS USE ON THE COURSE OF SCHIZOPHRENIA IN MALE PATIENTS: A PROSPECTIVE COHORT STUDY Schizophrenia Research. 136: S372. DOI: 10.1016/S0920-9964(12)71084-8  0.411
2012 Hedman AM, van Haren NE, van Baal CG, Kahn RS, Pol HEH. Poster #137 A META-ANALYSIS OF IQ CHANGE IN SCHIZOPHRENIA AND HEALTHY INDIVIDUALS Schizophrenia Research. 136: S329. DOI: 10.1016/S0920-9964(12)70969-6  0.411
2012 Vorstman l, Anney R, Derks E, Gallagher L, Gill M, Jonge Md, Engeland Hv, Kahn R, Ophoff R. Poster #112 NO EVIDENCE THAT COMMON GENETIC RISK VARIANTS ARE SHARED BETWEEN SCHIZOPHRENIA AND AUTISM Schizophrenia Research. 136. DOI: 10.1016/S0920-9964(12)70945-3  0.371
2012 van Haren NE, Schnack HG, Cahn W, Pol HEH, Kahn RS. Poster #53 CORTICAL THICKNESS AND CORTICAL SURFACE IN SCHIZOPHRENIA: TWO DISTINCT BUT RELEVANT PROCESSES? Schizophrenia Research. 136: S299-S300. DOI: 10.1016/S0920-9964(12)70886-1  0.363
2012 Mandl RCW, Rais M, Baal GCv, Haren Nv, Cairn W, Kahn RS, Pol HEH. Poster #46 ALTERED WHITE MATTER CONNECTIONS IN NEVER-MEDICATED PATIENTS WITH SCHIZOPHRENIA Schizophrenia Research. 136. DOI: 10.1016/S0920-9964(12)70879-4  0.391
2012 Vink M, Zandbelt BB, van Buuren M, Kahn RS. Poster #36 REDUCED PROACTIVE INHIBITORY CONTROL IN SCHIZOPHRENIA PATIENTS AND THEIR UNAFFECTED SIBLINGS Schizophrenia Research. 136: S293-S294. DOI: 10.1016/S0920-9964(12)70869-1  0.808
2012 Renes RA, Vermeulen L, Kahn RS, Aarts H, van Haren NE. Poster #162 DISTURBED SELF-AGENCY IN SCHIZOPHRENIA DUE TO ABNORMAL IMPLICIT (BUT NOT EXPLICIT) PROCESSING OF ACTION-OUTCOME INFORMATION Schizophrenia Research. 136: S244. DOI: 10.1016/S0920-9964(12)70734-X  0.359
2012 Nieuwenhuis M, Haren NEv, Pol HEH, Cahn W, Kahn RS, Schnack HG. Poster #56 CLASSIFICATION OF SCHIZOPHRENIA PATIENTS AND HEALTHY CONTROLS FROM STRUCTURAL MRI SCANS VERIFIED IN TWO LARGE INDEPENDENT SAMPLES Schizophrenia Research. 136. DOI: 10.1016/S0920-9964(12)70628-X  0.404
2012 Collin G, Van den Heuvel MP, De Reus MA, Boos HB, Calm W, Pol HEH, Kahn RS. Poster #48 FRONTOSTRIATAL DEPENDENCY IN GREY MATTER VOLUME IS REDUCED IN SCHIZOPHRENIA Schizophrenia Research. 136: S202-S203. DOI: 10.1016/S0920-9964(12)70620-5  0.418
2012 Breetvelt EJ, Aukes MF, Boks MP, Kahn RS, Ophoff RA. Poster #106 IN A NORMAL POPULATION SAMPLE SCHIZOPHRENIA ASSOCIATED COPY NUMBER VARIATIONS IN GENOMIC REGIONS 1Q21.1, 15Q11.2 ARE MORE FREQUENT IN FEMALE AND ARE ASSOCIATED WITH LOWER SOCIOECONOMIC STATUS, OBESITY AND HIGHER CHOLESTEROL LEVELS Schizophrenia Research. 136: S129-S130. DOI: 10.1016/S0920-9964(12)70421-8  0.306
2012 Bergen AHv, Termorshuizen F, Smeets HM, Sommer IE, Kahn RS, Boks MPM. Poster #95 IS CLOZAPINE TREATMENT ASSOCIATED WITH LOWER MORTALITY RATES IN SCHIZOPHRENIA? PRELIMINARY EVIDENCE FROM A REGISTER BASED STUDY Schizophrenia Research. 136. DOI: 10.1016/S0920-9964(12)70410-3  0.354
2012 de Leeuw M, Vink M, Zandbelt BB, Kahn RS. Poster #22 HYPERACTIVATION IN WORKING MEMORY CIRCUITS IN SIBLINGS OF SCHIZOPHRENIA PATIENTS: AN FMRI STUDY Schizophrenia Research. 136: S99. DOI: 10.1016/S0920-9964(12)70338-9  0.799
2012 Collin G, Pol HEH, Haijma SV, Cahn W, Kahn RS, Heuvel MPVd. Poster #19 IMPAIRED CEREBELLAR FUNCTIONAL CONNECTIVITY IN SCHIZOPHRENIA PATIENTS AND THEIR HEALTHY SIBLINGS Schizophrenia Research. 136. DOI: 10.1016/S0920-9964(12)70335-3  0.433
2012 Sommer IE, Witte LDd, Begemann M, Kahn RS. 14:45 Non-Steroidal Anti-Inflammatory Drugs In Schizophrenia: Ready For Practice Or A Good Start? A Meta-Analysis Schizophrenia Research. 136. DOI: 10.1016/S0920-9964(12)70276-1  0.321
2012 van Scheltinga AT, Bakker S, van Haren N, Boos H, Caln W, Nothen M, Rietschel M, Cichon S, Pol HH, Ophoff R, Kahn R. 14:00 COMMON POLYGENIC VARIATION CONTRIBUTING TO SCHIZOPHRENIA RISK EXPLAINS VARIATION IN TOTAL BRAIN VOLUME Schizophrenia Research. 136: S72. DOI: 10.1016/S0920-9964(12)70264-5  0.413
2012 Kahn R. Effects Of Physical Exercise On Psychotic Symptoms, Cognition And Brain Structure: Results Of A Randomized Clinical Trial In Chronic Schizophrenia Schizophrenia Research. 136. DOI: 10.1016/S0920-9964(12)70206-2  0.341
2012 Kahn RS. WHY ANTIPSYCHOTICS ARE GOOD FOR THE BRAIN Schizophrenia Research. 136: S51. DOI: 10.1016/S0920-9964(12)70185-8  0.322
2012 Kahn RS. PROGRESSIVE CHANGESIN BRAIN STRUCTUREIN SCHIZOPHRENIA-CLINICAL OUTCOME, MEDICATION AND HERITABILITY Schizophrenia Research. 136: S19. DOI: 10.1016/S0920-9964(12)70066-X  0.382
2012 Kahn R. Brain Changes In Schizophrenia And Bipolar Disorder: Is There A Genetic Overlap? Schizophrenia Research. 136. DOI: 10.1016/S0920-9964(12)70027-0  0.406
2011 Collin G, Hulshoff Pol HE, Haijma SV, Cahn W, Kahn RS, van den Heuvel MP. Impaired cerebellar functional connectivity in schizophrenia patients and their healthy siblings. Frontiers in Psychiatry. 2: 73. PMID 22203807 DOI: 10.3389/Fpsyt.2011.00073  0.474
2011 Boonstra G, Burger H, Grobbee DE, Kahn RS. Antipsychotic prophylaxis is needed after remission from a first psychotic episode in schizophrenia patients: results from an aborted randomised trial. International Journal of Psychiatry in Clinical Practice. 15: 128-34. PMID 22121861 DOI: 10.3109/13651501.2010.534801  0.312
2011 van den Heuvel MP, Kahn RS. Abnormal brain wiring as a pathogenetic mechanism in schizophrenia. Biological Psychiatry. 70: 1107-8. PMID 22115412 DOI: 10.1016/J.Biopsych.2011.10.020  0.429
2011 Zandi T, Havenaar JM, Laan W, Kahn RS, van den Brink W. Predictive validity of a culturally informed diagnosis of schizophrenia: a 30 month follow-up study with first episode psychosis. Schizophrenia Research. 133: 29-35. PMID 22019074 DOI: 10.1016/J.Schres.2011.09.024  0.405
2011 Kas MJ, Kahn RS, Collier DA, Waddington JL, Ekelund J, Porteous DJ, Schughart K, Hovatta I. Translational neuroscience of schizophrenia: seeking a meeting of minds between mouse and man. Science Translational Medicine. 3: 102mr3. PMID 21957171 DOI: 10.1126/Scitranslmed.3002917  0.366
2011 Zandbelt BB, van Buuren M, Kahn RS, Vink M. Reduced proactive inhibition in schizophrenia is related to corticostriatal dysfunction and poor working memory. Biological Psychiatry. 70: 1151-8. PMID 21903198 DOI: 10.1016/J.Biopsych.2011.07.028  0.817
2011 van Haren NE, Schnack HG, Cahn W, van den Heuvel MP, Lepage C, Collins L, Evans AC, Hulshoff Pol HE, Kahn RS. Changes in cortical thickness during the course of illness in schizophrenia. Archives of General Psychiatry. 68: 871-80. PMID 21893656 DOI: 10.1001/Archgenpsychiatry.2011.88  0.397
2011 Daalman K, van Zandvoort M, Bootsman F, Boks M, Kahn R, Sommer I. Auditory verbal hallucinations and cognitive functioning in healthy individuals. Schizophrenia Research. 132: 203-7. PMID 21839618 DOI: 10.1016/J.Schres.2011.07.013  0.356
2011 Boonstra G, Cahn W, Schnack HG, Hulshoff Pol HE, Minderhoud TC, Kahn RS, van Haren NE. Duration of untreated illness in schizophrenia is not associated with 5-year brain volume change. Schizophrenia Research. 132: 84-90. PMID 21835595 DOI: 10.1016/J.Schres.2011.07.018  0.384
2011 Volavka J, Czobor P, Derks EM, Bitter I, Libiger J, Kahn RS, Fleischhacker WW. Efficacy of antipsychotic drugs against hostility in the European First-Episode Schizophrenia Trial (EUFEST). The Journal of Clinical Psychiatry. 72: 955-61. PMID 21824456 DOI: 10.4088/Jcp.10M06529  0.414
2011 de Weijer AD, Mandl RC, Diederen KM, Neggers SF, Kahn RS, Hulshoff Pol HE, Sommer IE. Microstructural alterations of the arcuate fasciculus in schizophrenia patients with frequent auditory verbal hallucinations. Schizophrenia Research. 130: 68-77. PMID 21641775 DOI: 10.1016/J.Schres.2011.05.010  0.393
2011 van Hell HH, Bossong MG, Jager G, Kahn RS, Ramsey NF. Methods of the pharmacological imaging of the cannabinoid system (PhICS) study: towards understanding the role of the brain endocannabinoid system in human cognition. International Journal of Methods in Psychiatric Research. 20: 10-27. PMID 21574207 DOI: 10.1002/Mpr.327  0.543
2011 van Buuren M, Vink M, Rapcencu AE, Kahn RS. Exaggerated brain activation during emotion processing in unaffected siblings of patients with schizophrenia. Biological Psychiatry. 70: 81-7. PMID 21531384 DOI: 10.1016/J.Biopsych.2011.03.011  0.706
2011 Malik P, Kemmler G, Hummer M, Riecher-Roessler A, Kahn RS, Fleischhacker WW. Sexual dysfunction in first-episode schizophrenia patients: results from European First Episode Schizophrenia Trial. Journal of Clinical Psychopharmacology. 31: 274-80. PMID 21508850 DOI: 10.1097/Jcp.0B013E3182199Bcc  0.415
2011 van Veelen NM, Vink M, Ramsey NF, van Buuren M, Hoogendam JM, Kahn RS. Prefrontal lobe dysfunction predicts treatment response in medication-naive first-episode schizophrenia. Schizophrenia Research. 129: 156-62. PMID 21497488 DOI: 10.1016/J.Schres.2011.03.026  0.754
2011 Buizer-Voskamp JE, Laan W, Staal WG, Hennekam EA, Aukes MF, Termorshuizen F, Kahn RS, Boks MP, Ophoff RA. Paternal age and psychiatric disorders: findings from a Dutch population registry. Schizophrenia Research. 129: 128-32. PMID 21489755 DOI: 10.1016/J.Schres.2011.03.021  0.626
2011 van Hell HH, Bossong MG, Jager G, Kristo G, van Osch MJ, Zelaya F, Kahn RS, Ramsey NF. Evidence for involvement of the insula in the psychotropic effects of THC in humans: a double-blind, randomized pharmacological MRI study. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 14: 1377-88. PMID 21489346 DOI: 10.1017/S1461145711000526  0.556
2011 Daalman K, Boks MP, Diederen KM, de Weijer AD, Blom JD, Kahn RS, Sommer IE. The same or different? A phenomenological comparison of auditory verbal hallucinations in healthy and psychotic individuals. The Journal of Clinical Psychiatry. 72: 320-5. PMID 21450152 DOI: 10.4088/Jcp.09M05797Yel  0.351
2011 Koning JP, Tenback DE, Kahn RS, Vollema MG, Cahn W, van Harten PN. Movement disorders are associated with schizotypy in unaffected siblings of patients with non-affective psychosis. Psychological Medicine. 41: 2141-7. PMID 21426602 DOI: 10.1017/S0033291711000389  0.37
2011 Boonstra G, van Haren NE, Schnack HG, Cahn W, Burger H, Boersma M, de Kroon B, Grobbee DE, Hulshoff Pol HE, Kahn RS. Brain volume changes after withdrawal of atypical antipsychotics in patients with first-episode schizophrenia. Journal of Clinical Psychopharmacology. 31: 146-53. PMID 21346618 DOI: 10.1097/Jcp.0B013E31820E3F58  0.428
2011 Koning JP, Kahn RS, Tenback DE, van Schelven LJ, van Harten PN. Movement disorders in nonpsychotic siblings of patients with nonaffective psychosis. Psychiatry Research. 188: 133-7. PMID 21277026 DOI: 10.1016/J.Psychres.2011.01.005  0.355
2011 van Veelen NM, Vink M, Ramsey NF, Sommer IE, van Buuren M, Hoogendam JM, Kahn RS. Reduced language lateralization in first-episode medication-naive schizophrenia. Schizophrenia Research. 127: 195-201. PMID 21237617 DOI: 10.1016/J.Schres.2010.12.013  0.736
2011 Zandi T, Havenaar JM, Kahn RS, van den Brink W. Incidence of schizophrenia among Moroccan immigrants to The Netherlands. Response to letter written by Selten et al. Schizophrenia Research. 128: 173-4. PMID 21146960 DOI: 10.1016/J.Schres.2010.11.010  0.329
2011 Kahn RS, Linszen DH, Van Os J, Wiersma D, Bruggeman R, Cahn W, De Haan L, Krabbendam L, Myin-Germeys I. Evidence that familial liability for psychosis is expressed as differential sensitivity to cannabis: An analysis of patient-sibling and sibling-control pairs Archives of General Psychiatry. 68: 138-147. PMID 20921112 DOI: 10.1001/Archgenpsychiatry.2010.132  0.319
2011 Magnée MJ, Kahn RS, Cahn W, Kemner C. More prolonged brain activity related to gaze cueing in schizophrenia. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 122: 506-11. PMID 20702135 DOI: 10.1016/J.Clinph.2010.07.014  0.389
2011 Vorstman JA, van Daalen E, Jalali GR, Schmidt ER, Pasterkamp RJ, de Jonge M, Hennekam EA, Janson E, Staal WG, van der Zwaag B, Burbach JP, Kahn RS, Emanuel BS, van Engeland H, Ophoff RA. A double hit implicates DIAPH3 as an autism risk gene. Molecular Psychiatry. 16: 442-51. PMID 20308993 DOI: 10.1038/Mp.2010.26  0.626
2011 van Hell H, Jansma J, Bossong M, Kahn R, Ramsey N. P.6.c.005 Endocannabinoid involvement in brain reward processing in nicotine addiction European Neuropsychopharmacology. 21: S578. DOI: 10.1016/S0924-977X(11)70945-2  0.474
2011 van Hell H, Jansma J, Bossong M, Jager G, Noorman K, Kahn R, Ramsey N. P.1.e.031 Endocannabinoids may not be involved in response inhibition in humans European Neuropsychopharmacology. 21: S321. DOI: 10.1016/S0924-977X(11)70509-0  0.454
2011 Bossong M, Jansma J, van Hell H, Jager G, Kahn R, Ramsey N. P.1.e.007 The effects of delta9-tetrahydrocannabinol (THC) on human brain function involved in emotional processing: a pharmacological fMRI study European Neuropsychopharmacology. 21: S307. DOI: 10.1016/S0924-977X(11)70485-0  0.492
2011 Bossong M, Jansma J, van Hell H, Jager G, Kahn R, Ramsey N. P.1.e.006 Involvement of the endocannabinoid system in executive function: a pharmacological fMRI study with delta9-tetrahydrocannabinol (THC) European Neuropsychopharmacology. 21: S306-S307. DOI: 10.1016/S0924-977X(11)70484-9  0.473
2011 Sommer I, Diederen K, Neggers S, Kahn R. S.09.05 fTMS and treatment of psychiatric disorders European Neuropsychopharmacology. 21: S201. DOI: 10.1016/S0924-977X(11)70277-2  0.314
2011 Hulshoff Pol H, Cahn W, Kahn R. S.01.05 Can neuroimaging in schizophrenia predict antipsychotic response European Neuropsychopharmacology. 21: S185-S186. DOI: 10.1016/S0924-977X(11)70238-3  0.395
2011 Scheewe TW, Haren NEMv, Takken T, Backx FJG, Kahn RS, Cahn W. P.4.013 Association between physical activity, fitness and global brain volumes in patients with schizophrenia and matched healthy controls European Neuropsychopharmacology. 21. DOI: 10.1016/S0924-977X(11)70102-X  0.425
2011 Van Hell HH, Vink M, Ossewaarde L, Jager G, Kahn RS, Ramsey NF. Chronic effects of cannabis use on the human reward system: An fMRI study | Efectos crónicos del consumo de cannabis sobre el sistema de recompensa humano: un estudio de RMf Psiquiatria Biologica. 18: 45-54. DOI: 10.1016/J.Psiq.2011.08.003  0.673
2010 Diederen KM, De Weijer AD, Daalman K, Blom JD, Neggers SF, Kahn RS, Sommer IE. Decreased language lateralization is characteristic of psychosis, not auditory hallucinations. Brain : a Journal of Neurology. 133: 3734-44. PMID 21097491 DOI: 10.1093/Brain/Awq313  0.33
2010 Schnack HG, van Haren NE, Brouwer RM, van Baal GC, Picchioni M, Weisbrod M, Sauer H, Cannon TD, Huttunen M, Lepage C, Collins DL, Evans A, Murray RM, Kahn RS, Hulshoff Pol HE. Mapping reliability in multicenter MRI: voxel-based morphometry and cortical thickness. Human Brain Mapping. 31: 1967-82. PMID 21086550 DOI: 10.1002/Hbm.20991  0.453
2010 Van der Schot A, Kahn R, Ramsey N, Nolen W, Vink M. Trait and state dependent functional impairments in bipolar disorder. Psychiatry Research. 184: 135-42. PMID 21050725 DOI: 10.1016/J.Pscychresns.2010.07.009  0.729
2010 Rais M, van Haren NE, Cahn W, Schnack HG, Lepage C, Collins L, Evans AC, Hulshoff Pol HE, Kahn RS. Cannabis use and progressive cortical thickness loss in areas rich in CB1 receptors during the first five years of schizophrenia. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 20: 855-65. PMID 20863671 DOI: 10.1016/J.Euroneuro.2010.08.008  0.409
2010 van der Schot AC, Vonk R, Brouwer RM, van Baal GC, Brans RG, van Haren NE, Schnack HG, Boomsma DI, Nolen WA, Hulshoff Pol HE, Kahn RS. Genetic and environmental influences on focal brain density in bipolar disorder. Brain : a Journal of Neurology. 133: 3080-92. PMID 20837502 DOI: 10.1093/Brain/Awq236  0.363
2010 Grootens KP, van Veelen NM, Sitskoorn MM, Sabbe BG, Peuskens J, Buitelaar JK, Verkes RJ, Kahn RS. Effects on cognitive functioning after olanzapine-ziprasidone crossover in recent-onset schizophrenia. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 20: 907-12. PMID 20833514 DOI: 10.1016/J.Euroneuro.2010.08.003  0.386
2010 Vinkers CH, Mirza NR, Olivier B, Kahn RS. The inhibitory GABA system as a therapeutic target for cognitive symptoms in schizophrenia: investigational agents in the pipeline. Expert Opinion On Investigational Drugs. 19: 1217-33. PMID 20812877 DOI: 10.1517/13543784.2010.513382  0.38
2010 van Veelen NM, Vink M, Ramsey NF, Kahn RS. Left dorsolateral prefrontal cortex dysfunction in medication-naive schizophrenia. Schizophrenia Research. 123: 22-9. PMID 20724113 DOI: 10.1016/J.Schres.2010.07.004  0.768
2010 de Weijer AD, Mandl RC, Sommer IE, Vink M, Kahn RS, Neggers SF. Human fronto-tectal and fronto-striatal-tectal pathways activate differently during anti-saccades. Frontiers in Human Neuroscience. 4: 41. PMID 20631846 DOI: 10.3389/Fnhum.2010.00041  0.637
2010 Derks EM, Fleischhacker WW, Boter H, Peuskens J, Kahn RS. Antipsychotic drug treatment in first-episode psychosis: should patients be switched to a different antipsychotic drug after 2, 4, or 6 weeks of nonresponse? Journal of Clinical Psychopharmacology. 30: 176-80. PMID 20520291 DOI: 10.1097/Jcp.0B013E3181D2193C  0.328
2010 van Lutterveld R, Oranje B, Kemner C, Abramovic L, Willems AE, Boks MP, Glenthøj BY, Kahn RS, Sommer IE. Increased psychophysiological parameters of attention in non-psychotic individuals with auditory verbal hallucinations. Schizophrenia Research. 121: 153-9. PMID 20494553 DOI: 10.1016/J.Schres.2010.04.017  0.424
2010 van Veelen NM, Grootens KP, Peuskens J, Sabbe BG, Salden ME, Verkes RJ, Kahn RS, Sitskoorn MM. Short term neurocognitive effects of treatment with ziprasidone and olanzapine in recent onset schizophrenia. Schizophrenia Research. 120: 191-8. PMID 20493663 DOI: 10.1016/J.Schres.2010.04.011  0.371
2010 Laan W, Grobbee DE, Selten JP, Heijnen CJ, Kahn RS, Burger H. Adjuvant aspirin therapy reduces symptoms of schizophrenia spectrum disorders: results from a randomized, double-blind, placebo-controlled trial. The Journal of Clinical Psychiatry. 71: 520-7. PMID 20492850 DOI: 10.4088/Jcp.09M05117Yel  0.409
2010 Koolschijn PC, van Haren NE, Cahn W, Schnack HG, Janssen J, Klumpers F, Hulshoff Pol HE, Kahn RS. Hippocampal volume change in schizophrenia. The Journal of Clinical Psychiatry. 71: 737-44. PMID 20492835 DOI: 10.4088/Jcp.08M04574Yel  0.434
2010 Breetvelt EJ, Boks MP, Numans ME, Selten JP, Sommer IE, Grobbee DE, Kahn RS, Geerlings MI. Schizophrenia risk factors constitute general risk factors for psychiatric symptoms in the population. Schizophrenia Research. 120: 184-90. PMID 20421160 DOI: 10.1016/J.Schres.2010.03.033  0.334
2010 Brans RG, Kahn RS, Schnack HG, van Baal GC, Posthuma D, van Haren NE, Lepage C, Lerch JP, Collins DL, Evans AC, Boomsma DI, Hulshoff Pol HE. Brain plasticity and intellectual ability are influenced by shared genes. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 5519-24. PMID 20410105 DOI: 10.1523/Jneurosci.5841-09.2010  0.328
2010 Zandi T, Havenaar JM, Smits M, Limburg-Okken AG, van Es H, Cahn W, Algra A, Kahn RS, van den Brink W. First contact incidence of psychotic disorders among native Dutch and Moroccan immigrants in the Netherlands: influence of diagnostic bias. Schizophrenia Research. 119: 27-33. PMID 20332065 DOI: 10.1016/J.Schres.2010.02.1059  0.331
2010 Van Haren NE, Koolschijn PC, Cahn W, Schnack HG, Hulshoff Pol HE, Kahn RS. Cigarette smoking and progressive brain volume loss in schizophrenia. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 20: 454-8. PMID 20227855 DOI: 10.1016/J.Euroneuro.2010.02.009  0.325
2010 Gaebel W, Riesbeck M, von Wilmsdorff M, Burns T, Derks EM, Kahn RS, Rössler W, Fleischhacker WW. Drug attitude as predictor for effectiveness in first-episode schizophrenia: Results of an open randomized trial (EUFEST). European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 20: 310-6. PMID 20202800 DOI: 10.1016/J.Euroneuro.2010.02.001  0.338
2010 Diederen KM, Neggers SF, Daalman K, Blom JD, Goekoop R, Kahn RS, Sommer IE. Deactivation of the parahippocampal gyrus preceding auditory hallucinations in schizophrenia. The American Journal of Psychiatry. 167: 427-35. PMID 20123912 DOI: 10.1176/Appi.Ajp.2009.09040456  0.36
2010 van Buuren M, Gladwin TE, Zandbelt BB, Kahn RS, Vink M. Reduced functional coupling in the default-mode network during self-referential processing. Human Brain Mapping. 31: 1117-27. PMID 20108218 DOI: 10.1002/Hbm.20920  0.774
2010 van Hell HH, Vink M, Ossewaarde L, Jager G, Kahn RS, Ramsey NF. Chronic effects of cannabis use on the human reward system: an fMRI study. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 20: 153-63. PMID 20061126 DOI: 10.1016/J.Euroneuro.2009.11.010  0.696
2010 Réthelyi JM, Bakker SC, Polgár P, Czobor P, Strengman E, Pásztor PI, Kahn RS, Bitter I. Association study of NRG1, DTNBP1, RGS4, G72/G30, and PIP5K2A with schizophrenia and symptom severity in a Hungarian sample. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 153: 792-801. PMID 19937977 DOI: 10.1002/Ajmg.B.31049  0.403
2010 Boter H, Derks EM, Fleischhacker WW, Davidson M, Kahn RS. Generalizability of the results of efficacy trials in first-episode schizophrenia: comparisons between subgroups of participants of the European First Episode Schizophrenia Trial (EUFEST). The Journal of Clinical Psychiatry. 71: 58-65. PMID 19852905 DOI: 10.4088/Jcp.08M04506Yel  0.359
2010 Koolschijn PC, van Haren NE, Bakker SC, Hoogendoorn ML, Hulshoff Pol HE, Kahn RS. Effects of brain-derived neurotrophic factor Val66Met polymorphism on hippocampal volume change in schizophrenia. Hippocampus. 20: 1010-7. PMID 19714565 DOI: 10.1002/Hipo.20699  0.422
2010 Koolschijn PC, van Haren NE, Lensvelt-Mulders GJ, Hulshoff Pol HE, Kahn RS. Brain volume abnormalities in major depressive disorder: a meta-analysis of magnetic resonance imaging studies. Human Brain Mapping. 30: 3719-35. PMID 19441021 DOI: 10.1002/Hbm.20801  0.308
2010 Mandl RC, Schnack HG, Luigjes J, van den Heuvel MP, Cahn W, Kahn RS, Hulshoff Pol HE. Tract-based analysis of magnetization transfer ratio and diffusion tensor imaging of the frontal and frontotemporal connections in schizophrenia. Schizophrenia Bulletin. 36: 778-87. PMID 19042913 DOI: 10.1093/Schbul/Sbn161  0.421
2010 Koning JP, Tenback DE, van Os J, Aleman A, Kahn RS, van Harten PN. Dyskinesia and parkinsonism in antipsychotic-naive patients with schizophrenia, first-degree relatives and healthy controls: a meta-analysis. Schizophrenia Bulletin. 36: 723-31. PMID 18990712 DOI: 10.1093/Schbul/Sbn146  0.427
2010 Vink M, Zandbelt BB, Buuren Mv, Kahn RS. Stop-signal response inhibition deficits in schizophrenia patients and their unaffected siblings F1000research. 1. DOI: 10.7490/F1000Research.694.1  0.806
2010 Kahn R. Why treating early, treating well, and treating for life is important in schizophrenia Annals of General Psychiatry. 9. DOI: 10.1186/1744-859X-9-S1-S67  0.459
2010 Boos H, Cahn W, Van Haren N, Derks E, Brouwer R, Schnack H, Pol HH, Kahn R. P.1.e.018 Focal and global brain measurements in non-psychotic siblings of patients with schizophrenia European Neuropsychopharmacology. 20: S298-S299. DOI: 10.1016/S0924-977X(10)70397-7  0.417
2010 Jager G, van Hell H, Bossong M, Kristo G, Kahn R, Ramsey N. P.1.e.009 Delta9-THC induces non-specific psychotropic effects reflected in resting-state brain function: a pharmaco-imaging study European Neuropsychopharmacology. 20: S293. DOI: 10.1016/S0924-977X(10)70388-6  0.498
2010 Bossong M, van Hell H, Jager G, Oudman F, Kahn R, Ramsey N. P.1.e.005 Delta9-tetrahydrocannabinol (THC) impairs working memory system capacity: a pharmacological MRI study European Neuropsychopharmacology. 20: S290-S291. DOI: 10.1016/S0924-977X(10)70384-9  0.47
2010 Aukes M, Alizadeh B, Kemner C, Sitskoorn M, Ophoff R, Kahn R. S.24.02 Cognitive endophenotypes in schizophrenia European Neuropsychopharmacology. 20: S199-S200. DOI: 10.1016/S0924-977X(10)70218-2  0.377
2010 van Hell H, Jager G, Brouwer A, Bossong M, Kahn R, Ramsey N. P.3.024 Addiction proneness: contribution of the endocannabinoid system and reward processing European Neuropsychopharmacology. 20: S82. DOI: 10.1016/S0924-977X(10)70096-1  0.459
2010 Bossong M, van Hell H, Jager G, Oudman F, Kahn R, Ramsey N. P.3.003 Involvement of the endocannabinoid system in working memory: a pharmacological MRI study with delta9-THC European Neuropsychopharmacology. 20: S64. DOI: 10.1016/S0924-977X(10)70075-4  0.467
2010 van Haren N, Brans R, van Baal C, Schnack H, Kahn R, Hulshoff Pol H. S34-02 - Heritability of cortical thickness change over time in schizophrenia patients and their discordant co-twins European Psychiatry. 25: 96. DOI: 10.1016/S0924-9338(10)70096-1  0.438
2010 Marsman A, Van den Heuvel MP, Mandl RC, Kahn RS, Hulshoff Pol HE. GLUTAMATE IN SCHIZOPHRENIA - A REVIEW Schizophrenia Research. 117: 477. DOI: 10.1016/J.Schres.2010.02.899  0.378
2010 Widschwendter CG, Vink M, Zandbelt BB, Kahn RS. EVIDENCE FOR DECREASED FRONTO-STRIATAL FUNCTIONING IN SCHIZOPHRENIA DURING WORKING MEMORY Schizophrenia Research. 117: 476. DOI: 10.1016/J.Schres.2010.02.897  0.797
2010 Hoogendam JM, van Veelen NM, Vink M, Kahn RS. DECREASED LANGUAGE LATERALIZATION IN MEDICATION NAIVE SCHIZOPHRENIA Schizophrenia Research. 117: 475-476. DOI: 10.1016/J.Schres.2010.02.896  0.671
2010 Heuvel MPvd, Mandl RCW, Scheeuwe T, Kahn W, Kahn RS, Pol HEH. Functional Connectivity In Schizophrenia Schizophrenia Research. 117: 475-475. DOI: 10.1016/J.Schres.2010.02.894  0.413
2010 van Buuren M, Vink M, Kahn RS. ABERRANT COUPLING WITHIN THE DEFAULT-MODE NETWORK DURING SELF-REFERENTIAL PROCESSING IN HEALTHY SIBLINGS OF SCHIZOPHRENIA PATIENTS Schizophrenia Research. 117: 474. DOI: 10.1016/J.Schres.2010.02.893  0.676
2010 Ziermans TB, Schothorst PF, Schnack HG, Wit Sd, Kahn RS, Engeland Hv, Durston S. Progressive Structural Brain Changes Are Associated With Onset Of Psychosis Schizophrenia Research. 117: 464-464. DOI: 10.1016/J.Schres.2010.02.869  0.307
2010 Van Baal GCM, Pol HEH, Schnack HG, Brouwer RM, Brans RG, Kahn RS. CORTICAL THICKNESS IN SCHIZOPHRENIA AND BIPOLAR DISEASE: A TWIN MRI STUDY OF DISEASE-SPECIFIC AND COMORBID ENDOPHENOTYPES Schizophrenia Research. 117: 463. DOI: 10.1016/J.Schres.2010.02.867  0.378
2010 Schnack HG, Haren NEMv, Brouwer RM, Baal GCMv, Picchioni M, Weisbrod M, Sauer H, Cannon TD, Huttunen M, Lepage C, Collins DL, Evans A, Murray RM, Kahn RS, Pol HEH. Mapping Reliability Of Multicenter Mri: Cortical Thickness And Voxel-Based Morphometry Schizophrenia Research. 117: 461-461. DOI: 10.1016/J.Schres.2010.02.861  0.561
2010 Terwisscha van Schel AF, Bakker SC, van Haren NE, Pol HEH, Cahn W, Buizer-Voskamp JE, Gladwin TE, Vorstman JA, Ophoff RA, Kahn RS. ASSOCIATION STUDY OF CNVS WITH BRAIN VOLUME AND BRAIN VOLUME CHANGE OVER 5 YEARS IN SCHIZOPHRENIA PATIENTS AND HEALTHY CONTROLS Schizophrenia Research. 117: 454. DOI: 10.1016/J.Schres.2010.02.845  0.421
2010 Terwisscha van Schel AF, Bakker SC, van Haren NE, Pol HEH, Cahn W, Ophoff RA, Kahn RS. FIBROBLAST GROWTH FACTORS AND BRAIN VOLUME IN SCHIZOPHRENIA PATIENTS AND HEALTHY CONTROLS Schizophrenia Research. 117: 453. DOI: 10.1016/J.Schres.2010.02.844  0.419
2010 van Veelen NM, Vink M, Ramsey NF, Kahn RS. LEFT PRE-FRONTAL LOBE DYSFUNCTION IN MEDICATION NAIVE SCHIZOPHRENIA Schizophrenia Research. 117: 359. DOI: 10.1016/J.Schres.2010.02.631  0.735
2010 Aukes MF, Boks MP, Willems AE, van Lutterveld R, Sommer IE, Sitskoorn MM, Ophoff RA, Alizadeh BZ, Kahn RS. A GENOME-WIDE LINKAGE SCAN OF THETA BAND ACTIVITY AS AN ENDOPHENOTYPE FOR SCHIZOPHRENIA Schizophrenia Research. 117: 243-244. DOI: 10.1016/J.Schres.2010.02.370  0.401
2010 Boos HB, Cahn W, Van Haren NE, Derks EM, Brouwer RM, Schnack HG, Hulshoff Pol HE, Kahn RS. CORTICAL THICKNESS IN PATIENTS WITH SCHIZOPHRENIA AND THEIR SIBLINGS Schizophrenia Research. 117: 223. DOI: 10.1016/J.Schres.2010.02.322  0.419
2010 Boonstra G, van Haren NE, Schnack HG, Cahn W, Burger H, Boersma M, Grobbee DE, Hulshoff Pol HE, Kahn RS. BRAIN VOLUME CHANGES AFTER WITHDRAWAL OF ATYPICAL ANTIPSYCHOTICS IN FIRST-EPISODE SCHIZOPHRENIA PATIENTS Schizophrenia Research. 117: 223. DOI: 10.1016/J.Schres.2010.02.321  0.447
2010 Buizer-Voskamp JE, Laan W, Boks MPM, Staal WG, Hennekam EAM, Aukes MF, Kahn RS, Ophoff RA. Parental Age And The Risk Of Psychiatric Disorders Schizophrenia Research. 117: 194-194. DOI: 10.1016/J.Schres.2010.02.255  0.589
2010 van Haren NE, Rijsdijk F, Schnack H, Picchioni M, Weisbrod M, Sauer H, van Erp TG, Cannon TD, Boomsma D, Hulshoff Pol HE, Murray RM, Kahn RS. THE STAR CONSORTIUM: DO GENES OR ENVIRONMENT EXPLAIN THE ASSOCIATION BETWEEN SCHIZOPHRENIA AND A SMALLER BRAIN? Schizophrenia Research. 117: 171-172. DOI: 10.1016/J.Schres.2010.02.200  0.397
2010 Schnack HG, van Haren NE, Cahn W, Hulshoff Pol HE, Kahn RS. EXCESSIVE FOCAL BRAIN CHANGES IN SCHIZOPHRENIA: DIFFERENT AGE TRAJECTORIES MEASURED WITH LONGITUDINAL MRI Schizophrenia Research. 117: 533-534. DOI: 10.1016/J.Schres.2010.02.1049  0.411
2010 Somers M, Sommer IE, Kahn RS. OPTIMIZATION OF TREATMENT AND MANAGEMENT OF SCHIZOPHRENIA IN EUROPE: THE OPTIMISE TRIAL Schizophrenia Research. 117: 528-529. DOI: 10.1016/J.Schres.2010.02.1019  0.346
2010 van der Doef TF, Bossong MG, Boellaard R, Yaqub M, Kloet R, Schuitemaker A, van Haren N, Windhorst AD, Cahn W, Lammertsma AA, Kahn RS, van Berckel BN. Microglia activation in schizophrenia Neuroimage. 52: S145. DOI: 10.1016/J.Neuroimage.2010.04.119  0.417
2009 Galderisi S, Davidson M, Kahn RS, Mucci A, Boter H, Gheorghe MD, Rybakowski JK, Libiger J, Dollfus S, López-Ibor JJ, Peuskens J, Hranov LG, Fleischhacker WW. Correlates of cognitive impairment in first episode schizophrenia: the EUFEST study. Schizophrenia Research. 115: 104-14. PMID 19822407 DOI: 10.1016/J.Schres.2009.09.022  0.363
2009 Boter H, Peuskens J, Libiger J, Fleischhacker WW, Davidson M, Galderisi S, Kahn RS. Effectiveness of antipsychotics in first-episode schizophrenia and schizophreniform disorder on response and remission: an open randomized clinical trial (EUFEST). Schizophrenia Research. 115: 97-103. PMID 19819114 DOI: 10.1016/J.Schres.2009.09.019  0.333
2009 Kemner C, Foxe JJ, Tankink JE, Kahn RS, Lamme VA. Abnormal timing of visual feedback processing in young adults with schizophrenia. Neuropsychologia. 47: 3105-10. PMID 19631672 DOI: 10.1016/J.Neuropsychologia.2009.07.009  0.374
2009 Grootens KP, van Veelen NM, Peuskens J, Sabbe BG, Thys E, Buitelaar JK, Verkes RJ, Kahn RS. Ziprasidone vs olanzapine in recent-onset schizophrenia and schizoaffective disorder: results of an 8-week double-blind randomized controlled trial. Schizophrenia Bulletin. 37: 352-61. PMID 19542525 DOI: 10.1093/Schbul/Sbp037  0.424
2009 van 't Wout M, van Rijn S, Jellema T, Kahn RS, Aleman A. Deficits in implicit attention to social signals in schizophrenia and high risk groups: behavioural evidence from a new illusion. Plos One. 4: e5581. PMID 19440352 DOI: 10.1371/Journal.Pone.0005581  0.402
2009 Laan W, Smeets H, de Wit NJ, Kahn RS, Grobbee DE, Burger H. Glucocorticosteroids associated with a decreased risk of psychosis. Journal of Clinical Psychopharmacology. 29: 288-90. PMID 19440085 DOI: 10.1097/Jcp.0B013E3181A44575  0.334
2009 Terwisscha van Scheltinga AF, Bakker SC, Kahn RS. Fibroblast growth factors in schizophrenia. Schizophrenia Bulletin. 36: 1157-66. PMID 19429845 DOI: 10.1093/Schbul/Sbp033  0.402
2009 Magnée MJ, Oranje B, van Engeland H, Kahn RS, Kemner C. Cross-sensory gating in schizophrenia and autism spectrum disorder: EEG evidence for impaired brain connectivity? Neuropsychologia. 47: 1728-32. PMID 19397868 DOI: 10.1016/J.Neuropsychologia.2009.02.012  0.425
2009 Davidson M, Galderisi S, Weiser M, Werbeloff N, Fleischhacker WW, Keefe RS, Boter H, Keet IP, Prelipceanu D, Rybakowski JK, Libiger J, Hummer M, Dollfus S, López-Ibor JJ, Hranov LG, ... ... Kahn RS, et al. Cognitive effects of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: a randomized, open-label clinical trial (EUFEST). The American Journal of Psychiatry. 166: 675-82. PMID 19369319 DOI: 10.1176/Appi.Ajp.2008.08060806  0.383
2009 Rietkerk T, Boks MPM, Sommer IEC, Jong Sd, Kahn RS, Ophoff RA. Network analysis of positional candidate genes of schizophrenia highlights myelin-related pathways Molecular Psychiatry. 14: 353-355. PMID 19308022 DOI: 10.1038/Mp.2008.86  0.359
2009 Peper JS, Schnack HG, Brouwer RM, Van Baal GC, Pjetri E, Székely E, van Leeuwen M, van den Berg SM, Collins DL, Evans AC, Boomsma DI, Kahn RS, Hulshoff Pol HE. Heritability of regional and global brain structure at the onset of puberty: a magnetic resonance imaging study in 9-year-old twin pairs. Human Brain Mapping. 30: 2184-96. PMID 19294640 DOI: 10.1002/Hbm.20660  0.333
2009 Derks EM, Verweij KH, Kahn RS, Cahn WC. The calculation of familial loading in schizophrenia. Schizophrenia Research. 111: 198-9. PMID 19268542 DOI: 10.1016/J.Schres.2009.02.013  0.348
2009 van den Heuvel MP, Mandl RC, Kahn RS, Hulshoff Pol HE. Functionally linked resting-state networks reflect the underlying structural connectivity architecture of the human brain. Human Brain Mapping. 30: 3127-41. PMID 19235882 DOI: 10.1002/Hbm.20737  0.306
2009 van der Schot AC, Vonk R, Brans RG, van Haren NE, Koolschijn PC, Nuboer V, Schnack HG, van Baal GC, Boomsma DI, Nolen WA, Hulshoff Pol HE, Kahn RS. Influence of genes and environment on brain volumes in twin pairs concordant and discordant for bipolar disorder. Archives of General Psychiatry. 66: 142-51. PMID 19188536 DOI: 10.1001/Archgenpsychiatry.2008.541  0.345
2009 van Buuren M, Gladwin TE, Zandbelt BB, van den Heuvel M, Ramsey NF, Kahn RS, Vink M. Cardiorespiratory effects on default-mode network activity as measured with fMRI. Human Brain Mapping. 30: 3031-42. PMID 19180557 DOI: 10.1002/Hbm.20729  0.778
2009 Oranje B, Gispen-de Wied CC, Westenberg HG, Kemner C, Verbaten MN, Kahn RS. Haloperidol counteracts the ketamine-induced disruption of processing negativity, but not that of the P300 amplitude. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 12: 823-32. PMID 19154656 DOI: 10.1017/S1461145708009814  0.588
2009 Somers M, Sommer IE, Boks MP, Kahn RS. Hand-preference and population schizotypy: a meta-analysis. Schizophrenia Research. 108: 25-32. PMID 19106036 DOI: 10.1016/J.Schres.2008.11.010  0.361
2009 Cahn W, Rais M, Stigter FP, van Haren NE, Caspers E, Hulshoff Pol HE, Xu Z, Schnack HG, Kahn RS. Psychosis and brain volume changes during the first five years of schizophrenia. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 19: 147-51. PMID 19056248 DOI: 10.1016/J.Euroneuro.2008.10.006  0.448
2009 Grootens KP, Vermeeren L, Verkes RJ, Buitelaar JK, Sabbe BG, van Veelen N, Kahn RS, Hulstijn W. Psychomotor planning is deficient in recent-onset schizophrenia. Schizophrenia Research. 107: 294-302. PMID 19008079 DOI: 10.1016/J.Schres.2008.09.032  0.401
2009 Peper JS, Brouwer RM, Schnack HG, Baal GCMv, Leeuwen Mv, Berg SMvd, Waal HDd, Boomsma DI, Kahn RS, Pol HEH. Sex steroids and brain structure in pubertal boys and girls Psychoneuroendocrinology. 34: 332-342. PMID 18980810 DOI: 10.1016/J.Psyneuen.2008.09.012  0.315
2009 Vorstman JA, Turetsky BI, Sijmens-Morcus ME, de Sain MG, Dorland B, Sprong M, Rappaport EF, Beemer FA, Emanuel BS, Kahn RS, van Engeland H, Kemner C. Proline affects brain function in 22q11DS children with the low activity COMT 158 allele. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 739-46. PMID 18769474 DOI: 10.1038/Npp.2008.132  0.351
2009 Bossong MG, van Berckel BN, Boellaard R, Zuurman L, Schuit RC, Windhorst AD, van Gerven JM, Ramsey NF, Lammertsma AA, Kahn RS. Delta 9-tetrahydrocannabinol induces dopamine release in the human striatum. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 759-66. PMID 18754005 DOI: 10.1016/J.Neuroimage.2008.04.231  0.498
2009 Vorstman JA, Chow EW, Ophoff RA, van Engeland H, Beemer FA, Kahn RS, Sinke RJ, Bassett AS. Association of the PIK4CA schizophrenia-susceptibility gene in adults with the 22q11.2 deletion syndrome. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 150: 430-3. PMID 18646052 DOI: 10.1002/Ajmg.B.30827  0.392
2009 Vink M, Zandbelt B, van Buuren M, Kahn R, Gladwin T. Anticipation and execution of response inhibition Neuroimage. 47: S190. DOI: 10.1016/S1053-8119(09)72124-X  0.757
2009 van Buuren M, Gladwin T, Zandbelt B, Kahn R, Vink M. Activity and connectivity within the default-mode network during self-referential processing after removal of cardiorespiratory confounds Neuroimage. 47: S133. DOI: 10.1016/S1053-8119(09)71304-7  0.758
2009 Zandbelt B, Hoogendam J, Van Buuren M, Sack A, Kahn R, Vink M. Repetitive Transcranial Magnetic Stimulation Alters Resting-State Functional Connectivity Neuroimage. 47: S74. DOI: 10.1016/S1053-8119(09)70478-1  0.758
2009 van Berckel B, Yaqub M, Bossong M, Boellaard R, Schuitemaker A, Lammertsma A, Windhorst A, Rozemuller A, Cahn W, Kahn R. P.3.f.007 Microglia is widespread activated in recent onset schizophrenia: evidence from PET and post mortem studies European Neuropsychopharmacology. 19: S585. DOI: 10.1016/S0924-977X(09)70936-8  0.359
2009 Grootens K, van Veelen N, Sitskoorn M, Verkes R, Kahn R. P.3.c.064 Effects of olanzapine and ziprasidone on cognitve outcome in recent-onset schizophrenia European Neuropsychopharmacology. 19: S547. DOI: 10.1016/S0924-977X(09)70871-5  0.375
2009 Fleischhacker W, Kahn R, Karayal O, Siu C, Pappadopulos E. P.3.c.034 Eufest: the moderating impact of metabolic co-morbidities on treatment outcomes in first-episode schizophrenia European Neuropsychopharmacology. 19. DOI: 10.1016/S0924-977X(09)70841-7  0.344
2009 Bossong M, Van Hell H, Jager G, Brouwer A, Kahn R, Ramsey N. P.1.e.015 Involvement of the endocannabinoid system in associative memory: a pharmacological MRI study European Neuropsychopharmacology. 19: S308-S309. DOI: 10.1016/S0924-977X(09)70459-6  0.47
2009 van Hell H, Bossong M, Jager G, Saliasi E, Kahn R, Ramsey N. P.1.e.014 The acute effects of delta-9-tetrahydro-cannabinol (THC) on brain activity during working memory European Neuropsychopharmacology. 19: S308. DOI: 10.1016/S0924-977X(09)70458-4  0.487
2009 Buizer-Voskamp J, Muntjewerff J, Vorstman J, Franke L, Hochstenbach P, Ophoff R, Kahn R. P.1.04 Schizophrenia and cytogenetic aberrations: in search of susceptibility genes and pathways European Neuropsychopharmacology. 19: S5-S6. DOI: 10.1016/S0924-977X(09)70007-0  0.375
2009 van Leeuwen M, Peper JS, van den Berg SM, Brouwer RM, Hulshoff Pol HE, Kahn RS, Boomsma DI. A genetic analysis of brain volumes and IQ in children Intelligence. 37: 181-191. DOI: 10.1016/J.Intell.2008.10.005  0.302
2008 Aukes MF, Alizadeh BZ, Sitskoorn MM, Kemner C, Ophoff RA, Kahn RS. Genetic overlap among intelligence and other candidate endophenotypes for schizophrenia. Biological Psychiatry. 65: 527-34. PMID 19013556 DOI: 10.1016/J.Biopsych.2008.09.020  0.349
2008 Mandl RC, Schnack HG, Zwiers MP, van der Schaaf A, Kahn RS, Hulshoff Pol HE. Functional diffusion tensor imaging: measuring task-related fractional anisotropy changes in the human brain along white matter tracts. Plos One. 3: e3631. PMID 18982065 DOI: 10.1371/Journal.Pone.0003631  0.31
2008 Brans RG, van Haren NE, van Baal GC, Schnack HG, Kahn RS, Hulshoff Pol HE. Heritability of changes in brain volume over time in twin pairs discordant for schizophrenia. Archives of General Psychiatry. 65: 1259-68. PMID 18981337 DOI: 10.1001/Archpsyc.65.11.1259  0.401
2008 Brans RG, van Haren NE, van Baal GC, Staal WG, Schnack HG, Kahn RS, Hulshoff Pol HE. Longitudinal MRI study in schizophrenia patients and their healthy siblings. The British Journal of Psychiatry : the Journal of Mental Science. 193: 422-3. PMID 18978326 DOI: 10.1192/Bjp.Bp.107.041467  0.694
2008 Zandbelt BB, Gladwin TE, Raemaekers M, van Buuren M, Neggers SF, Kahn RS, Ramsey NF, Vink M. Within-subject variation in BOLD-fMRI signal changes across repeated measurements: quantification and implications for sample size. Neuroimage. 42: 196-206. PMID 18538585 DOI: 10.1016/J.Neuroimage.2008.04.183  0.769
2008 van Berckel BN, Bossong MG, Boellaard R, Kloet R, Schuitemaker A, Caspers E, Luurtsema G, Windhorst AD, Cahn W, Lammertsma AA, Kahn RS. Microglia activation in recent-onset schizophrenia: a quantitative (R)-[11C]PK11195 positron emission tomography study. Biological Psychiatry. 64: 820-2. PMID 18534557 DOI: 10.1016/J.Biopsych.2008.04.025  0.413
2008 van Haren NE, Cahn W, Hulshoff Pol HE, Kahn RS. Schizophrenia as a progressive brain disease. European Psychiatry : the Journal of the Association of European Psychiatrists. 23: 245-54. PMID 18513927 DOI: 10.1016/J.Eurpsy.2007.10.013  0.434
2008 Kahn RS, Fleischhacker WW, Boter H, Davidson M, Vergouwe Y, Keet IP, Gheorghe MD, Rybakowski JK, Galderisi S, Libiger J, Hummer M, Dollfus S, López-Ibor JJ, Hranov LG, Gaebel W, et al. Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial. Lancet. 371: 1085-97. PMID 18374841 DOI: 10.1016/S0140-6736(08)60486-9  0.378
2008 van Rijn S, Aleman A, Swaab H, Vink M, Sommer I, Kahn RS. Effects of an extra X chromosome on language lateralization: an fMRI study with Klinefelter men (47,XXY). Schizophrenia Research. 101: 17-25. PMID 18372164 DOI: 10.1016/J.Schres.2008.02.001  0.65
Hide low-probability matches.